All publications

The complete bibliography of the team — 577 references, every journal and every author position.

For the shorter, curated view — journals with an impact factor above 10, with a team member in a signing author position — see the main publications page.

Back to selected publications

NoteSources

2019–2024 comes from the team’s HCERES bibliographic record, deduplicated across the 19 per-member sheets. Author lists are as recorded there, and each entry links to a PubMed search on its title.

2025–2026 comes from a PubMed search across team members with a Lyon affiliation; those entries carry a direct PubMed link and a DOI.

The HCERES record was compiled from Web of Science and contains a handful of namesake artefacts — a few references belong to other researchers who share a surname and initial with a team member. They are left in rather than removed by guesswork.

2026

• [Flow cytometry image atlas: lymphoproliferative syndromes - Additional images obtained on the XF1600]
  Sevestre J, Mayeur-Rousse C, Imbert S, Harrivel V, Letestu R, Baseggio L
  Ann Biol Clin (Paris) · PubMed · doi

• A step toward defining optimal liposomal amphotericin B treatment duration in pulmonary mucormycosis: results from emulated trials
  Coste A, Paccoud O, Danion F, Conrad A, Poirée S, Le Bourgeois A, Defrance C, Letscher-Bru V, et al.
  Antimicrob Agents Chemother · PubMed · doi

• Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipeline
  Mareschal S, Wucher V, Huet S, Léonce C, Chabane K, Hayette S, Bringuier PP, Pinson S, et al.
  Bioinformatics · PubMed · doi

• Durable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL
  Ahmed S, Martín García-Sancho A, Reguera Ortega JL, Cartron G, Rapoport AP, Izutsu K, Ghesquieres H, Goto H, et al.
  Blood · PubMed · doi

• Shrouded in a starry sky: a case of AML-MRC with KMT2A amplification mimicking Burkitt-like morphology
  Chiriac R, Alcazer V
  Blood · PubMed · doi

• Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis
  Gower N, Feugier P, Westin J, Schiano De Colella JM, Tilly H, Palomba ML, Julia E, Damaj GL, et al.
  Blood · PubMed · doi

• Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy
  Vodička P, El-Galaly TC, Procházka V, Flowers CR, Villa D, Dietrich CE, Jakobsen LH, Ghesquières H, et al.
  Blood · PubMed · doi

• CAR in R/R FL: is real-world efficacy meeting expectations?
  Bourbon E, Bachy E
  Blood Adv · PubMed · doi

• FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial
  Jamet B, Ahrari S, Zweegman S, Perrot A, Hulin C, Caillot D, Facon T, Leleu X, et al.
  Blood Adv · PubMed · doi

• A phase 1, first-in-human study of safimaltib, a MALT1 inhibitor, in B-lymphocytic malignancies
  Hertzberg M, Cheah CY, Opat S, Kalac M, Abrisqueta P, Ribrag V, Bachy E, Ysebaert L, et al.
  Blood Cancer Discov · PubMed · doi

• Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML
  Fenwarth L, Vasseur L, Duployez N, Boudry A, Gardin C, Penther D, Lambert J, de Botton S, et al.
  Blood Cancer J · PubMed · doi

• Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy
  Ghesquières H, Drouet Y, Slager SL, Morschhauser F, Julia E, Galimberti S, Robinson D, Larson MC, et al.
  Blood Cancer J · PubMed · doi

• Tamibarotene with venetoclax and azacitidine in RARAacute myeloid leukemia: results from the SY-1425-202 study
  Cluzeau T, Borate U, McMahon C, Fenaux P, Heiblig M, Peterlin P, Ball B, Chantepie S, et al.
  Blood Neoplasia · PubMed · doi

• BEAM versus EAM, FEAM, BeEAM, and TEAM: exploring conditioning strategies in autologous stem cell transplantation for Hodgkin lymphoma a retrospective study of the LWP of EBMT
  Paviglianiti A, Fekom M, Halahleh K, Benakli M, Aljurf M, Giebel S, Zinzani P, Cerretti R, et al.
  Bone Marrow Transplant · PubMed · doi

• Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group
  Tauveron-Jalenques U, Aspas Requena G, Gross Z, Tavernier E, Chorão P, Carre M, Cornillon J, Contejean A, et al.
  Bone Marrow Transplant · PubMed · doi

• Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium
  Dumas PY, Bertoli S, Bérard E, Santana C, Heiblig M, Leguay T, Tavitian S, Borgne E, et al.
  Br J Haematol · PubMed · doi

• Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study
  Benavente Y, Hermosa S, Papadimitriou N, Clay-Gilmour A, Brown EE, Hofmann JN, Rothman N, Lan Q, et al.
  Br J Haematol · PubMed · doi

• SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent
  Dubois S, Cherblanc F, Belot A, Oberic L, Ghesquières H, Haioun C, Tilly H, Jais JP, et al.
  Br J Haematol · PubMed · doi

• Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia
  Larrue C, Angelino P, Mouche S, Green AS, Boet E, Boussaid I, Perez-Carretero C, Birsen R, et al.
  Cell Rep Med · PubMed · doi

• Ruxolitinib for life-threatening corticosteroid-refractory hypereosinophilic syndrome: A multicenter case series
  Gros C, Rohmer J, Lefèvre G, Abraham J, Bardol J, Bodard Q, Chebrek S, Duployez N, et al.
  Clin Immunol · PubMed · doi

• Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study
  Lapierre L, Laemmel L, Bérard E, Rigolot L, Bidet A, Higué J, Banos A, Béziat G, et al.
  Clin Lymphoma Myeloma Leuk · PubMed · doi

• Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma
  Febvey-Combes O, Rossi C, Kassai B, Murairi Mirimo T, Chartier L, Cherblanc F, Cugnod E, Ghesquières H, et al.
  Clin Pharmacol Ther · PubMed · doi

• Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen
  Blay JY, Lamure S, Waissi W, Sunyach MP, Bahri H, Rey P, Chassagne-Clement C, Nicolas-Virelizier E, et al.
  Eur J Cancer · PubMed · doi

• BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort
  Cazaubiel T, Decaux O, Perrot A, Royer B, Belhadj-Merzoug K, Macro M, Vincent L, Karlin L, et al.
  Eur J Haematol · PubMed · doi

• Plain language summary of a study on 30-minute intravenous infusion of isatuximab in people with newly diagnosed multiple myeloma
  Ocio EM, Perrot A, Moreau P, Mateos MV, Bringhen S, Martínez-López J, Karlin L, Oprea C, et al.
  Future Oncol · PubMed · doi

• Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study
  Lazarovici J, Amorim S, Bouabdallah K, Fournier M, Guidez S, Molina L, Morschhauser F, Delapierre B, et al.
  Haematologica · PubMed · doi

• Hypomethylating agents plus venetoclaxintensive chemotherapy prior to transplant in high-risk acute myeloid leukemia
  Berton G, Bewersdorf JP, Gilhodes J, Iat A, Soua A, DeAngelo DJ, Boussi L, Shallis RM, et al.
  Haematologica · PubMed · doi

• Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study
  Benoit A, Pages J, Szepetowski S, Agouti I, Thuret I, Le Roux E, Badens C, Brousse V, et al.
  Hemasphere · PubMed · doi

• Longitudinal assessments of MRD in high-risk newly diagnosed transplant-ineligible multiple myeloma in the BENEFIT study (IFM2020-05)
  Corre J, Lambert J, Bobin A, Manier S, Perrot A, Karlin L, Roussel M, Bigot N, et al.
  Hemasphere · PubMed · doi

• Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis
  Houot R, Lemoine J, Claudel A, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, et al.
  Hemasphere · PubMed · doi

• Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort
  Cheminant M, Fogarty P, Carras S, Sarkozy C, Rossi C, Fornecker L, Fontanet B, Chauchet A, et al.
  Hematol Oncol · PubMed · doi

• Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model
  Lachowiez CA, Zeidner JF, Othman J, Kaempf A, Yun S, Heiblig M, Heuser M, Shahswar R, et al.
  J Clin Oncol · PubMed · doi

• Molecular sleuthing: unmasking hidden lymphomas through plasma DNA sequencing
  Bonnot M, Bertin P, Maillet T, Guyotat N, Bloch J, Chevreux S, Mosnier I, Ghesquières H, et al.
  J Med Genet · PubMed · doi

• Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study
  Donzel M, Khedimallah S, Barriere S, Gouband A, Aubert C, Bosselut N, Poullot E, Bezsera SM, et al.
  Lancet Haematol · PubMed · doi

• Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma
  Vallois D, Missiaglia E, Veloza L, Fischer A, Cavalieri D, Rattina V, Bisig B, Roh V, et al.
  Leukemia · PubMed · doi

• Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia
  Vasseur L, Duchmann M, Duployez N, Raffoux E, Berthon C, Heiblig M, Genthon A, Braun T, et al.
  Leukemia · PubMed · doi

• Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry
  Heiblig M, Gross Z, Belhabri A, Tauveron-Jalenques U, Tavernier E, Requena Aspas G, Carré M, Contejean A, et al.
  Leukemia · PubMed · doi

• Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
  Hutchings M, Dickinson M, Gritti G, Carlo-Stella C, Townsend W, Bosch F, Bartlett NL, Cartron G, et al.
  Nat Med · PubMed · doi

• Multicentric data challenge for artificial intelligence-based classification of leukocytes: results from the CytologIA consortium
  Sourdeau E, Geneviève F, Baseggio L, Badaoui B, Chevalier C, Pannetier M, Janel A, Arbab A, et al.
  NPJ Precis Oncol · PubMed · doi

• Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases
  Sormani J, Belot A, Goncalves D, Dechomet M, Seve P, Hot A, Koppe L, Lemoine S, et al.
  Rev Med Interne · PubMed · doi

• Reactive and therapy induced bone marrow changes linked to systemic infectious and non-infectious disorders including MAS/HLH report from the European association for haematopathology, Dubrovnik 2024
  Green AC, Tzankov A, Weinberg O, Traverse-Glehen A, Saft L, Leguit RJ
  Virchows Arch · PubMed · doi

2025

• Comparative Efficacy of Talquetamab vs. Real-World Physician’s Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
  Einsele H, Moreau P, Bahlis N, Bhutani M, Vincent L, Karlin L, Perrot A, Goldschmidt H, et al.
  Adv Ther · PubMed · doi

• Pseudo-Chédiak-Higashi Inclusions in an Anaplastic Large Cell Lymphoma
  Chiriac R, Baseggio L
  Am J Hematol · PubMed · doi

• Blastoid-appearing lymphocytes in a case of leukemic marginal zone lymphoma
  Chiriac R, Bourbon E, Baseggio L
  Ann Biol Clin (Paris) · PubMed · doi

• [Pulmonary Castleman disease: At the crossroads of thoracic and hematologic pathology]
  Phélinas S, Donzel M, Traverse-Glehen A, Grima R, Richard M, Cottin V, Chalabreysse L, Lavrut PM
  Ann Pathol · PubMed · doi

• [Promoting pathology and cytology in OSCE: an integrated approach for optimal clinical training]
  Donzel M, Trecourt A, Benzerdjeb N, Devouassoux-Shisheboran M, Traverse-Glehen A, Decaussin-Petrucci M
  Ann Pathol · PubMed · doi

• Diagnostic value of the wnt target and cancer-associated blood biomarker hPG80: ONCOPRO case-control prospective study
  You B, Couraud S, Ceruse P, Badet L, Paparel P, Durand A, Guillet M, Merle P, et al.
  Biomark Res · PubMed · doi

• Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial
  Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, et al.
  Blood · PubMed · doi

• Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment
  Claudel A, Cottereau AS, Bachy E, Itti E, Feugier P, Rossi C, Lemonnier F, Camus V, et al.
  Blood · PubMed · doi

• Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
  Kraeber-Bodéré F, Jamet B, Zweegman S, Perrot A, Hulin C, Caillot D, Facon T, Leleu X, et al.
  Blood · PubMed · doi

• Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study
  Tournilhac O, Bouabdallah K, Lecolant S, Hacini M, Laribi K, Bailly S, Belmondo T, Maerevoet M, et al.
  Blood Adv · PubMed · doi

• ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development
  Andrieu GP, Hypolite G, Latiri M, Balducci E, Costa C, Verhoeyen E, Courgeon M, Allatif O, et al.
  Blood Adv · PubMed · doi

• DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
  Thomas N, García-Prieto CA, Dreval K, Hilton LK, Abramson JS, Bartlett NL, Bethony J, Bowen J, et al.
  Blood Cancer Discov · PubMed · doi

• Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
  Sarkozy C, Chartier L, Ribrag V, Gressin R, Geisler CH, Kluin-Nelemans HC, Thieblemont C, Morschhauser F, et al.
  Blood Cancer J · PubMed · doi

• Impact of elevated red blood cell membrane cholesterol in sickle cell anemia patients: Effects of BRN-002, a 2-hydroxypropyl-β-cyclodextrin derivate, on red blood cell lipids, deformability, sickling and hemolysis
  Bordat C, Connes P, Joly P, Poutrel S, Halfon-Domenech C, Perez A, Niesor E, Nader E
  Blood Cells Mol Dis · PubMed · doi

• Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse
  Touzeau C, Leleu X, Tiab M, Macro M, Perrot A, Gay J, Chateleix C, Moreau S, et al.
  Br J Haematol · PubMed · doi

• It is time to consider the climate crisis in haematology
  Noel R, Charbonnier A, Schell B, Dony A, Toulemonde C, Eisinger F, Decaux O, Lotocka J, et al.
  Clin Hematol Int · PubMed · doi

• Differences in oxygen-gradient ektacytometry parameters and blood viscosity between patients with sickle cell anemia and patients with sickle cell-hemoglobin C disorder
  Connes P, Martin M, Boisson C, Stauffer E, Renoux C, Joly P, Poutrel S, Halfon-Domenech C, et al.
  Clin Hemorheol Microcirc · PubMed · doi

• Real-World Utilization of Carfilzomib (Once or Twice Weekly) Initiated in Patients After a First Relapse Between 2017 and 2022 in France: An Analysis From a Large-Scale Epidemiology of Multiple MYeloma (EmmY) Cohort
  Hulin C, Belhadj Merzoug K, Royer B, Caillot D, Bobin A, Macro M, Karlin L, Mohty M, et al.
  Clin Lymphoma Myeloma Leuk · PubMed · doi

• Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study
  Trecourt A, Rabodonirina M, Donzel M, Simon B, Mauduit C, Traverse-Glehen A, Meyronet D, Ginevra C, et al.
  Clin Microbiol Infect · PubMed · doi

• CD200 expression in CD4T-cells: Diagnostic implications across T-cell lymphomas
  Chiriac R, Donzel M, Pourchet V, Baseggio L
  Cytometry B Clin Cytom · PubMed · doi

• Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA
  Sarkozy C, Molina TJ, Dubois S, Portugues C, Bohers E, Ysebaert L, Houot R, Pica GM, et al.
  EClinicalMedicine · PubMed · doi

• Sézary-Like Features in Atypical Vacuolated Cells of Adult T-Cell Leukemia/Lymphoma
  Chiriac R, Baseggio L
  EJHaem · PubMed · doi

• Large B-cell lymphoma: The LYSA pragmatic guidelines
  Sesques P, Manson G, Dubois S, Gros FX, Brisou G, Sarkozy C, Bernard S, Bourbon E, et al.
  Eur J Cancer · PubMed · doi

• Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient-Reported Outcomes
  Perrot A, Facon T, Plesner T, Usmani SZ, Kumar S, Bahlis NJ, Hulin C, Orlowski RZ, et al.
  Eur J Haematol · PubMed · doi

• Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles
  Fenwarth L, Podvin B, Vasseur L, Lebon D, Couillez G, Berthon C, Caulier A, Fournier E, et al.
  Eur J Haematol · PubMed · doi

• Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan
  Gribben JG, Bachy E, Ray M, Krupsky K, Beusterien K, Kopenhafer L, Beygi S, Best T, et al.
  Front Oncol · PubMed · doi

• Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphoma
  Bartlett NL, Hahn U, Kim WS, Fleury I, Laribi K, Bergua JM, Bouabdallah K, Forward N, et al.
  Future Oncol · PubMed · doi

• Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma
  Johnson NA, Zinzani PL, Domingo-Domenech E, Brody J, Kline J, Shah BD, Mehta AN, Ghesquieres H, et al.
  Future Oncol · PubMed · doi

• to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
  Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, et al.
  Haematologica · PubMed · doi

• Histomolecular Features of a Rare Subtype of Pleomorphic Adenoma Characterised by Abundant Lymphoid Stroma and HMGA2 Rearrangements
  Alsugair Z, Momenkhan S, Donzel M, Descotes F, Pissaloux D, Paindavoine S, Houlier A, Tirode F, et al.
  Head Neck Pathol · PubMed · doi

• Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database
  Grange T, Poullot E, Parrens M, Traverse-Glehen A, Syrykh C, Xerri L, Bruneau J, Fataccioli V, et al.
  Hemasphere · PubMed · doi

• Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis
  Galtier J, Sesques P, Dupont V, Bachy E, Di Blasi R, Thieblemont C, Brisou G, Gastinne T, et al.
  Hemasphere · PubMed · doi

• Implementation science in hemato-oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM)
  Cayuela JM, Sujobert P, Flandrin-Gresta P, Alary AS, Maute C, Luque-Paz D, Pastoret C, Dulucq S, et al.
  Hemasphere · PubMed · doi

• All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?
  Sarkozy C, Traverse-Glehen A
  Hematology Am Soc Hematol Educ Program · PubMed · doi

• Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses
  Moore A, Kane E, Teras LR, Machiela MJ, Arias J, Panagiotou OA, Monnereau A, Doo NW, et al.
  Int J Cancer · PubMed · doi

• CD200 Expression by CD4+ T Cells Using Flow Cytometry as a Valuable Marker for Distinguishing Hodgkin Lymphoma From Inflammatory Conditions
  Pourchet V, Chiriac R, Baseggio L
  Int J Lab Hematol · PubMed · doi

• Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study
  de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, Rouanet J, Ingen-Housz-Oro S, Orvain C, et al.
  J Clin Oncol · PubMed · doi

• Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
  Bartlett NL, Hahn U, Kim WS, Fleury I, Laribi K, Bergua JM, Bouabdallah K, Forward N, et al.
  J Clin Oncol · PubMed · doi

• FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma
  Maurer MJ, Prochazka VK, El-Galaly TC, Flowers CR, Villa D, Bachy E, Cahn EJ, Fournier M, et al.
  J Clin Oncol · PubMed · doi

• Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study
  Chari A, Touzeau C, Schinke C, Minnema MC, Berdeja JG, Oriol A, van de Donk NWCJ, Rodríguez-Otero P, et al.
  Lancet Haematol · PubMed · doi

• Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC
  Johnson-Ansah H, Charbonnier A, Etienne G, Roy L, Legros L, Roth-Guépin G, Orvain C, Bouvier A, et al.
  Leuk Res · PubMed · doi

• Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia
  Lebon D, Da Rocha A, Cassinat B, Heiblig M, Bertoli S, Bonmati C, Zilliox A, Laloi M, et al.
  Leukemia · PubMed · doi

• A molecular signature predicts hematologic evolution in polycythemia vera patients
  Mansier O, Lippert E, Benajiba L, Ranta D, Girodon F, Ianotto JC, Chauveau A, Roy L, et al.
  Leukemia · PubMed · doi

• Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model
  Tari Crochet G, Ari-Yuka S, Fischer A, Chour M, Claudel A, Sako N, Robe C, Naudet J, et al.
  Leukemia · PubMed · doi

• Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma
  Vallois D, Missiaglia E, Veloza L, Fischer A, Cavalieri D, Rattina V, Bisig B, Roh V, et al.
  Leukemia · PubMed · doi

• [Metabolism and therapy in acute myeloid leukemia with isocitrate dehydrogenase 1/2 mutations]
  Gabellier L, Bosetta E, Heiblig M, Sarry JE
  Med Sci (Paris) · PubMed · doi

• Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma
  Perrot A, Lambert J, Hulin C, Pieragostini A, Karlin L, Arnulf B, Rey P, Garderet L, et al.
  N Engl J Med · PubMed · doi

• T cell malignancies after CAR T cell therapy in the DESCAR-T registry
  Dulery R, Guiraud V, Choquet S, Thieblemont C, Bachy E, Barete S, Todesco È, Arnulf B, et al.
  Nat Med · PubMed · doi

• Intermediate-Dose Cytarabine as Postinduction AML Therapy
  Hunault M, Pautas C, Bertoli S, Dumas PY, Raffoux E, Hospital MA, Marchand T, Heiblig M, et al.
  NEJM Evid · PubMed · doi

• Myeloid Neoplasms with Evidence of the Additive/Cumulative Effect of Molecular Genetic Alterations That “Pave the Way” to a Specific Disease Category or Entity: Lessons Learned from Cases Submitted to the 22nd Meeting of the European Association for Haematopathology/Society of Hematopathology Bone Marrow Workshop Organized by the European Bone Marrow Working Group, Dubrovnik 2024
  Tzankov A, Green A, Leguit R, Saft L, Weinberg OK, Traverse-Glehen A
  Pathobiology · PubMed · doi

• Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity
  Larbre V, Ranchon F, Maucort-Boulch D, Coz E, Herledan C, Caffin AG, Baudouin A, Maire M, et al.
  Pharmaceuticals (Basel) · PubMed · doi

• The association between sarcoidosis and lymphoma: a retrospective and multicentre study of 46 patients
  Charriere R, El Jammal T, Bert A, Chalayer E, Kilian M, Gerfaud-Valentin M, Jamilloux Y, Ghesquieres H, et al.
  Sarcoidosis Vasc Diffuse Lung Dis · PubMed · doi

• Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia
  Martin M, Nader E, Rezigue H, Dargaud Y, Renoux C, Joly P, Heiblig M, Nougier C, et al.
  Semin Thromb Hemost · PubMed · doi

• Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering
  Hequet O, Mialou V, Cognasse F, Mazet S, Chelghoum Y, Revesz D, Candido C, Nicolas JF, et al.
  Transfus Clin Biol · PubMed · doi

• Patient-Reported Outcomes of CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients and Their Impact on Survival
  Spanjaart AM, Coz E, Rioufol C, Maucort-Boulch D, Roche S, Beijamini V, Vledder A, Ghesquieres H, et al.
  Transplant Cell Ther · PubMed · doi

• Metabolism and therapeutic response in acute myeloid leukemia with IDH1/2 mutations
  Gabellier L, Bosetta E, Heiblig M, Sarry JE
  Trends Cancer · PubMed · doi

2024

• A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French Registry
  Ray M, Castaigne JG, Zang A, Patel A, Hancock E, Brighton N, Bachy E
  Advances in Therapy · PubMed

• Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
  Ghergus D, Martin M, Knapp AM, Delmotte F, Joublin-Delavat A, Jung S, Schickel JN, Mendel I, Dupuis A, Drenou B, Ghesquieres H, Salles G, Baseggio L, Herbrecht R, Korganow AS, Vallat L, Soulas-Sprauel P, Meffre E, Martin T
  American Journal of Hematology · PubMed

• Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study
  Moraly J, Rossignol J, Rouzaud C, Gabas T, Bouktit H, Lhermitte L, Canioni D, Fraitag S, Bruneau J, Barete S, Suarez F, Ballul T, Meni C, Polivka L, Terriou L, Launay D, Bouillet L, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Neel A, Ranta D, Jaussaud R, Guilpain P, Frenzel L, Agopian J, Dubreuil P, Greco C, Dimicoli-Salazar S, Heiblig M, Gourguechon C, Tournilhac O, Javier RM, Castelain F, Cabrera Q, Gourin MP, Wierzbicka-Hainaut E, Torregrosa-Diaz JM, Bulai C, Lavigne C, Hoarau C, Arock M, Damaj G, Lortholary O, Hermine O
  American Journal of Hematology · PubMed

• Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin
  Heiblig M, Gourguechon C, Guilpain P, Bulai-Livideanu C, Barete S, Chantran Y, Agopian J, Brenet F, Dubreuil P, Lespinasse J, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Chatain C, Damaj G, Ballul T, Greco C, Polivka L, Frenzel L, Meni C, Bouktit H, Benabou D, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Neel A, Ranta D, Jaussaud R, Molina TJ, Bruneau J, Villarese P, Lhermitte L, Maouche-Chretien L, Temple M, Kosmider O, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Dimicoli-Salazar S, Torregrosa-Diaz JM, Wemeau M, Soria A, Arock M, Bodemer C, Lortholary O, Hermine O, Rossignol J
  American Journal of Hematology · PubMed

• Anaplastic large cell T-cell lymphoma: insights from cytological and immunological profiles across ten diverse cases
  Chiriac R, Donzel M, Baseggio L
  Annales De Biologie Clinique · PubMed

• ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?
  Bienvenu AL, Leray V, Guichon C, Bourget S, Chapuis C, Dureault A, Pavese P, Roux S, Kahale E, Chaabane W, Subtil F, Maucort-Boulch D, Talbot F, Dode X, Ghesquieres H, Leboucher G
  Annales Pharmaceutiques Francaises · PubMed

• Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of menin-KMT2A inhibitor therapy for acute myeloid leukaemia
  Tauveron-Jalenques U, Sarr K, Guieze R, Giordano C, Rouanet J, Hayette S, Chevenet C, Heiblig M, Ravinet A
  Annals of Hematology · PubMed

• Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
  Cottereau AS, Rebaud L, Trotman J, Feugier P, Nastoupil LJ, Bachy E, Flinn IW, Haioun C, Ysebaert L, Bartlett NL, Tilly H, Casasnovas O, Ricci R, Portugues C, Buvat I, Meignan M, Morschhauser F
  Annals of Oncology · PubMed

• Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
  Kim TM, Taszner M, Novelli S, Cho SG, Villasboas JC, Merli M, Jimenez-Ubieto A, Tessoulin B, Poon LM, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano L, Iskierka-Jazdzewska E, Tani M, Shen B, Uppala A, Zhu M, Shariff S, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Luminari S
  Annals of Oncology · PubMed

• Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
  de Valence B, Delaune M, Nguyen Y, Jachiet V, Heiblig M, Jean A, Tuczkiewicz SR, Henneton P, Guilpain P, Schleinitz N, Le Guenno G, Lobbes H, Lacombe V, Ardois S, Lazaro E, Langlois V, Outh R, Vinit J, Martellosio JP, Decker P, Moulinet T, Dieudonne Y, Bigot A, Terriou L, Vlakos A, de Maleprade B, Denis G, Broner J, Kostine M, Humbert S, Lifermann F, Samson M, Pechuzal S, Aouba A, Kosmider O, Dion J, Grosleron S, Bourguiba R, Terrier B, Georgin-Lavialle S, Fain O, Mekinian A, Morgand M, Comont T, Hadjadj J
  Annals of the Rheumatic Diseases · PubMed

• 18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden
  Sheng LS, Shen R, Yan ZX, Wang C, Zheng X, Zhang YL, Yang HX, Wu W, Xu PP, Cheng S, Bachy E, Sesques P, Jacquet-Francillon N, Jiang XF, Zhao WL, Wang L
  Biomarker Research · PubMed

• High efficacy of CD19 CAR T cells in patients with transformed Waldenstrom macroglobulinemia
  Durot E, Roos-Weil D, Chauchet A, Decroocq J, Di Blasi R, Gastinne T, Bensaber H, Cheminant M, Jacquet C, Guidez S, Gros FX, Bachy E, Coste A, Cony-Makhoul P, Treon SP, Delmer A, Reshef R, Le Gouill S, Castillo JJ, Houot R
  Blood · PubMed

• Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses
  von Jan J, Timonen S, Braun T, Jiang Q, Ianevski A, Peng YY, McConnell K, Sindaco P, Muller TA, Putzer S, Klepzig H, Jungherz D, Dechow A, Wahnschaffe L, Giri AK, Kankainen M, Kuusanmaeki H, Neubauer HA, Moriggl R, Mazzeo P, Schmidt N, Koch R, Hallek M, Chebel A, Armisen D, Genestier L, Bachy E, Mishra A, Schrader A, Aittokallio T, Mustjoki S, Herling M
  Blood · PubMed

• Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
  Crochet G, Iacoboni G, Couturier A, Bachy E, Iraola-Truchuelo J, Gastinne T, Cartron G, Fradon T, Lesne B, Kwon M, Gounot R, Martinez-Cibrian N, Castilla-Llorente C, Abrisqueta P, Guerreiro M, Sarkozy C, Aspa-Cilleruelo JM, Camus V, Guidez S, Chauchet A, Deconinck E, Bouabdallah K, Bosch F, Barba P, Morschhauser F, Houot R
  Blood · PubMed

• Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance
  Laurent C, Trisal P, Tesson B, Seth S, Beyou A, Roulland S, Lesne B, Van Acker N, Cerapio JP, Chartier L, Guille A, Stokes ME, Huang CC, Huet S, Gandhi AK, Morschhauser F, Xerri L
  Blood · PubMed

• Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
  Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Perez-Simon JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Paule I, Zia A, Awasthi R, Han X, Germano D, O’Donovan D, Ramos R, Maier HJ, Masood A, Thieblemont C, Schuster SJ
  Blood · PubMed

• The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
  Ghesquieres H, Krzisch D, Nicolas-Virelizier E, Kanoun S, Gac AC, Guidez S, Touati M, Laribi K, Morschhauser F, Bonnet C, Waultier-Rascalou A, Orsini-Piocelle F, Andre M, Fournier M, Morand F, Berriolo-Riedinger A, Burroni B, Damotte D, Traverse-Glehen A, Quittet P, Casasnovas O
  Blood · PubMed

• Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)
  Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson M, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Oluwole OO, Yakoub-Agha I, Khanal R, Rosenblatt J, Korn R, Peng WX, Lui C, Wulff J, Shen R, Poddar S, Jung AS, Miao H, Beygi S, Jacobson CA
  Blood · PubMed

• Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
  Gurnari C, Koster L, Baaij L, Heiblig M, Yakoub-Agha I, Collin M, Passweg J, Bulabois CE, Khan A, Loschi M, Carnevale-Schianca F, Crisa E, Caravelli D, Kuball J, Saraceni F, Olivieri A, Rambaldi A, Kulasekararaj AG, Hayden PJ, Badoglio M, Onida F, Scheid C, Franceschini F, Mekinian A, Savic S, Voso MT, Drozd-Sokolowska J, Snowden JA, Raj K, Alexander T, Robin M, Greco R, McLornan DP
  Blood Advances · PubMed

• Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)
  Vic S, Thibert JB, Bachy E, Cartron G, Gastinne T, Morschhauser F, Le Bras F, Bouabdallah K, Despas F, Mohty M, Casasnovas O, Choquet S, Bay JO, Castilla-Llorente C, Guffroy B, Loschi M, Rubio MT, Carras S, Guidez S, Rochelle LDL, Guillet M, Houot R
  Blood Advances · PubMed

• Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort
  Ghesquieres H, Cherblanc F, Belot A, Micon S, Bouabdallah KK, Esnault C, Fornecker LM, Thokagevistk K, Bonjour M, Bijou F, Haioun C, Morineau N, Ysebaert L, Damaj G, Tessoulin B, Guidez S, Morschhauser F, Thieblemont C, Chauchet A, Gressin R, Jardin F, Fruchart C, Laboure G, Fouillet L, Lionne-Huyghe P, Bonnet A, Lebras L, Amorim S, Leyronnas C, Olivier G, Guieze R, Houot R, Launay V, Drenou B, Fitoussi O, Detourmignies L, Abraham J, Soussain C, Lachenal F, Pica GM, Fogarty P, Cony-Makhoul P, Bernier A, Le Guyader-Peyrou S, Monnereau A, Boissard F, Rossi C, Camus V
  Blood Advances · PubMed

• Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
  Rejeski K, Wang YC, Hansen DK, Iacoboni G, Bachy E, Bansal R, Penack O, Muller F, Bethge W, Munoz J, Mohty R, Bucklein VL, Barba P, Locke FL, Lin Y, Jain MD, Subklewe M
  Blood Advances · PubMed

• Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study
  Renders S, Ngoya M, Finel H, Rubio MT, Townsend W, Schroers R, Novak U, Schaap N, Aljurf M, Helbig G, Collin M, Kobbe G, Huynh A, Perez-Simon JA, Bloor A, Ghesquieres H, Sureda A, Schmitz N, Glass B, Dreger P
  Blood Advances · PubMed

• Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
  Di Staso R, Casadei B, Locke FL, Jain M, Voorhees TJ, Kittai AS, Bastos-Oreiro M, Gutierrez A, Garcia-Sancho AM, Terol MJ, Mead M, Maranzano MJ, Iacoboni G, Barba P, Kwon M, Bailen R, Reguera-Ortega JL, Mian A, Hill B, Bachy E, Morschhauser F, Houot R, Thieblemont C, Le Gouill S, Masetti R, Gori D, Broccoli A, Zinzani PL, Argnani L
  Blood Cancer Journal · PubMed

• Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
  Ozogul E, Montaner A, Pol M, Frigola G, Balague O, Syrykh C, Bousquets-Munoz P, Royo R, Fontaine J, Traverse-Glehen A, Buhler MM, Giudici L, Roncador M, Zenz T, Carras S, Valmary-Degano S, de Leval L, Bosch-Schips J, Climent F, Salmeron-Villalobos J, Bashiri M, Ruiz-Gaspa S, Costa D, Bea S, Salaverria I, Gine E, Quintanilla-Martinez L, Brousset P, Raffeld M, Jaffe ES, Puente XS, Lopez C, Nadeu F, Campo E
  Blood Cancer Journal · PubMed

• Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years
  Berning P, Fekom M, Ngoya M, Goldstone AH, Dreger P, Montoto S, Finel H, Shumilov E, Chevallier P, Blaise D, Strussmann T, Carpenter B, Forcade E, Castilla-Llorente C, Trneny M, Ghesquieres H, Capria S, Thieblemont C, Blau IW, Meijer E, Broers AEC, Huynh A, Caillot D, Rosler W, Quoc SN, Bittenbring J, Nagler A, Galimard JE, Glass B, Sureda A, Schmitz N
  Blood Cancer Journal · PubMed

• Chronic lymphocytic leukaemia or mantle cell lymphoma?
  Chiriac R, Gazzo S, Baseggio L, Golfier C
  Bmj Case Reports · PubMed

• Haematological features of telomere biology disorders diagnosed in adulthood: A French nationwide study of 127 patients
  Maillet F, Galimard JE, Borie R, Lainey E, Larcher L, Passet M, Plessier A, Leblanc T, Terriou L, Lebon D, Alcazer V, Cathebras P, Loschi M, Wadih A, Marcais A, Marceau-Renaut A, Couque N, Lioure B, Soulier J, Ba I, Socie G, de Latour RP, Kannengiesser C, de Fontbrune FS
  British Journal of Haematology · PubMed

• Monomorphic epitheliotropic intestinal T-cell lymphoma involving the aqueous humour
  Chiriac R, Baseggio L
  British Journal of Haematology · PubMed

• Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients
  Alcazer V, Morisset S, Rea D, Legros L, Dulucq S, Hayette S, Cayuela JM, Huguet F, Mahon FX, Etienne G, Nicolini FE
  British Journal of Haematology · PubMed

• Red blood cell senescence and vascular function in patients with hereditary spherocytosis with and without splenectomy
  Casabianca M, Gauthier A, Nader E, Cannas G, Martin F, Martin M, Carin R, Boisson C, Guillot N, Merazga S, Renoux C, Bertrand Y, Garnier N, Hot A, Muniansi I, Halfon-Domenech C, Poutrel S, Joly P, Connes P
  British Journal of Haematology · PubMed

• SFCE harmonization workshops: Neonatal acute myeloid leukemia
  Ducassou S, Abou Chahla W, Duployez N, Halfon-Domenech C, Brethon B, Poiree M, de Beaumais TA, Lemaitre L, Sirvent N, Petit A
  Bulletin Du Cancer · PubMed

• Momelotinib as first-line or second-line treatment following ruxolitinib in patients with primary or secondary myelofibrosis
  Sudria A, Alcazer V
  Bulletin Du Cancer · PubMed

• Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma
  Ito Y, Marouf A, Kogure Y, Koya J, Lievin R, Bruneau J, Tabata M, Saito Y, Shingaki S, Yuasa M, Yamaguchi K, Murakami K, Weil R, Vavasseur M, Andrieu GP, Latiri M, Veleanu L, Dussiot M, Andre I, Joshi A, Lagresle-Peyrou C, Magerus A, Chaubard S, Lavergne D, Bachy E, Brunet E, Fataccioli V, Brouzes C, Laurent C, de Leval L, Traverse-Glehen A, Bossard C, Parrens M, Meignin V, Philippe L, Rossignol J, Suarez F, Michot JM, Tournilhac O, Damaj G, Lemonnier F, Bole-Feysot C, Nitschke P, Tesson B, Laurent C, Molina T, Asnafi V, Watatani Y, Chiba K, Okada A, Shiraishi Y, Tsukita S, Izutsu K, Miyoshi H, Ohshima K, Sakata S, Dobashi A, Takeuchi K, Sanada M, Gaulard P, Jaccard A, Ogawa S, Hermine O, Kataoka K, Couronne L
  Cancer Research · PubMed

• A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity
  Al Assi A, Posty S, Lamarche F, Chebel A, Guitton J, Cottet-Rousselle C, Prudent R, Lafanechere L, Giraud S, Dallemagne P, Suzanne P, Verney A, Genestier L, Castets M, Fontaine E, Billaud M, Cordier-Bussat M
  Cell Death & Disease · PubMed

• Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma
  Krug A, Mhaidly R, Tosolini M, Mondragon L, Tari G, Turtos AM, Paul-Bellon R, Asnafi V, Marchetti S, Di Mascio L, Travert M, Bost F, Bachy E, Arguello RJ, Fournie JJ, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E
  Cell Death Discovery · PubMed

• Human myeloid differentiation by BMP4 signaling through the VDR pathway in acute myeloid leukemia
  Zylbersztejn F, Byelinska I, Jeanpierre S, Barral L, Geistlich K, Flores-Violante M, Voeltzel T, Paubelle E, Heiblig M, Alcazer V, Le Meur G, Fossard G, Belhabri A, Cruz-Moura I, Hermine O, Lefort S, Maguer-Satta V
  Cell Death Discovery · PubMed

• A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma
  Ghione P, Palomba ML, Ray MD, Limbrick-Oldfield EH, Owen J, Kanters S, Bobillo S, Ribiero MT, Jacobson CA, Neelapu SS, Ghesquieres H, Nahas M, Beygi S, Patel AR, Gribben JG
  Clinical Lymphoma Myeloma & Leukemia · PubMed

• Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways
  Hidaoui D, Porquet A, Chelbi R, Bohm M, Polyzou A, Alcazer V, Depil S, Imanci A, Morabito M, Renneville A, Selimoglu-Buet D, Thepot S, Itzykson R, Laplane L, Droin N, Trompouki E, Elvira-Matelot E, Solary E, Porteu F
  Communications Biology · PubMed

• A batch of Phoenician ostraca discovered in Kition (Larnaca, Cyprus)
  Chatonnet F
  Comptes Rendus Des Seances De L Academie Des Inscriptions & Belles-Lettres · PubMed

• Central nervous system relapse of an extranodal natural killer/T-cell lymphoma
  Chiriac R, Baseggio L, Golfier C
  Ejhaem · PubMed

• Neoplastic plasma cells with concomitant azurophilic crystalline inclusions and Snapper-Schneid bodies
  Chiriac R, Gerland LM, Baseggio L
  Ejhaem · PubMed

• Terminal deoxynucleotidyl transferase-positive high-grade B-cell lymphoma with MYC and BCL2 rearrangements transformed from follicular lymphoma
  Chiriac R, Baseggio L, Donzel M
  Ejhaem · PubMed

• Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort
  Anota A, Basset M, Charton E, Bommier C, Efficace F, Dupuis J, Cottone F, Bouabdallah KK, Mollevi C, Ysebaert L, Winter A, Bijou F, Preau M, Chauchet A, Bernier A, Fornecker LM, Hafirassou H, Carras S, Lachenal F, Lionne-Huyghe P, Detourmignies L, Leyronnas C, Drenou B, Peyrou SL, Abraham J, Monnereau A, Fouillet L, Morschhauser F, Rossi C, Belot A, Ghesquieres H
  European Journal of Cancer · PubMed

• Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines
  Rossi C, Manson G, Marouf A, Cebannes-Hamy A, Nicolas-Virelizier E, Maerevoet M, Alcantara M, Molina L, Ceraulo A, Poiree M, Galtier J, Diop N, Delette C, Segot A, Dubois S, Waultier A, Bernard S, Noel R, Guidez S, Kohn M, Bailly S, Moatti H, Touati M, Renaud L, Kanoun S, Cottereau AS, Kirova Y, Peignaux K, Dourthe ME, Simonin M, Leblanc T, Quero L, Krzisch D, Dulery R, Grenier A, Gastinne T, Casasnovas O, Gallamini A, Andre M, Morschhauser F, Deau B, Fornecker LM, Ghesquieres H
  European Journal of Cancer · PubMed

• A shared developmental genetic basis for sexually antagonistic male and female adaptations in the toothed water strider
  Pruvot C, Armisen D, Roux P, Arnqvist G, Rowe L, Husby A, Khila A
  Evolution Letters · PubMed

• End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy
  Sesques P, Karlin L, Massy E, Maarek A, Aussedat G, Lazareth A, Golfier C, Bouafia-Sauvy F, Lequeu H, Ghergus D, Safar V, Ferrant E, Bachy E, Ghesquieres H, Confavreux CB, Demangel D, Perrial E, Dumontet C
  Frontiers in Oncology · PubMed

• Editorial: Tyrosine kinases and phosphatases in T- cell malignancies
  Tesio M
  Frontiers in Oncology · PubMed

• Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
  Herbaux C, Bret C, Bachy E, Bories P, Di Blasi R, Cuffel A, Gastinne T, Lamy T, Roussel M, Bouabdallah K, Beauvais D, Cartron G, Bay JO, Blaise D, Rubio MT, Mohty M, Le Bras F, Casasnovas O, Guy J, Guidez S, Llorente CC, Hermine O, La Rochelle LD, Carras S, Guffroy B, Caillat-Zucman S, Houot R, Le Gouill S
  Haematologica · PubMed

• IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma
  Stathis A, Pirosa MC, Orsucci L, Feugier P, Tani M, Ghesquieres H, Musuraca G, Rossi FG, Merli F, Guieze R, Gyan E, Gini G, Marino D, Gressin R, Morschhauser F, Cavallo F, Palombi F, Conconi A, Tessoulin B, Tilly H, Zanni M, Cabras MG, Capochiani E, Califano C, Celli M, Pulsoni A, Angrilli F, Occhini U, Casasnovas RO, Cartron G, Devizzi L, Haioun C, Liberati AM, Houot R, Merli M, Pietrantuono G, Re F, Spina M, Landi F, Cavalli F, Bertoni F, Rossi D, Ielmini N, Borgo E, Luminari S, Zucca E, Thieblemont C
  Haematologica · PubMed

• Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
  Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C
  Haematologica · PubMed

• Indirect treatment comparisons: how to MAIC it right?
  Bachy E
  Haematologica · PubMed

• Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a genomic profile distinct from that of ?d T-cell large granular lymphocytic leukemia
  Desmares A, Bouzy S, Thonier F, Goustille J, Llamas-Gutierrez F, Genevieve F, Cottin L, Baseggio L, Lemaire P, Lafon CL, Cornillet-Lefebvre P, Galoisy AC, Brouzes C, Rault E, Dindinaud E, Fleury C, Blanc-Jouvan F, Wuilleme S, Bardet V, Fest T, Lamy T, Roussel M, Pannetier M, Pastoret C
  Haematologica · PubMed

• Tell me who you go with and I’ll tell you who you are
  Tesio M
  Hemasphere · PubMed

• How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann-Pick disease type C from bone marrow and peripheral blood smears
  Girard S, Pettazzoni M, Froissart R, Pagan C, Boyer T, Dulucq S, Monteiro VG, Lechevalier N, Loosveld M, Lours C, Mayeur-Rousse C, Pannetier M, Peillon C, Rosenthal MA, Hieng SS, Trichet C, Baseggio L
  Hemasphere · PubMed

• Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data
  Gross Z, Veyrat-Masson R, Grange B, Huet S, Verney A, Traverse-Glehen A, Ruminy P, Baseggio L
  Hematological Oncology · PubMed

• Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
  Lan CL, Belot A, Golfier C, Audin B, Sesques P, Bernier A, Safar V, Ferrant E, Lazareth A, Lequeu H, Karlin L, Ghergus D, Maarek A, Aussedat G, Idlhaj M, Salles G, Cherblanc F, Bachy E, Ghesquieres H
  Hematological Oncology · PubMed

• Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study
  Bommier C, Donzel M, Rossi C, Fornecker LM, Bijou F, Chauchet A, Lebras L, Ysabaert L, Haioun C, Bouabdallah K, Gastinne T, Morineau N, Amorim S, Jardin F, Abraham J, de la Chapelle TL, Gressin R, Fouillet L, Fruchart C, Olivier G, Morschhauser F, Cherblanc F, Belot A, Le Guyader S, Monnereau A, Ghesquieres H, Thieblemont C
  Hematological Oncology · PubMed

• Cellular plasticity in peripheral T cell lymphomas
  Schrader A, Bardel E, Perret M, Verney A, Chatonnet F, Carras S, Bachy E, Genestier L
  Hematologie · PubMed

• Lymphomas
  Baseggio L, Bernard O
  Hematologie · PubMed

• Exogenous IL-2 delays memory precursors generation and is essential for enhancing memory cells effector functions
  Wang SY, Prieux M, de Bernard S, Dubois M, Laubreton D, Djebali S, Zala M, Arpin C, Genestier L, Leverrier Y, Gandrillon O, Crauste F, Jiang WZ, Marvel J
  Iscience · PubMed

• Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes
  Polivka L, Madrange M, Bulai-Livideanu C, Barete S, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Burdet C, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Damaj G, Frenzel L, Meni C, Bouktit H, Collange AF, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Canioni D, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Hermine O, Rossignol J
  Journal of Allergy and Clinical Immunology · PubMed

• Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
  Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas RO, Ysebaert L, Damaj GL, Guidez S, Pica GM, Kim WS, Lim ST, Andre M, Gutierrez N, Penarrubia MJ, Staber PB, Trotman J, Huettmann A, Stefoni V, Tucci A, Fogarty P, Farhat H, Abraham J, Abarah W, Belmecheri F, Ribrag V, Delfau-Larue MH, Cottereau AS, Itti E, Li J, Delarue R, de Leval L, Morschhauser F, Bachy E
  Journal of Clinical Oncology · PubMed

• Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study
  Kim R, Chalandon Y, Rousselot P, Cayuela JM, Huguet F, Balsat M, Passet M, Chevallier P, Hicheri Y, Raffoux E, Leguay T, Chantepie S, Maury S, Hayette S, Solly F, Braun T, De Prijck B, Cacheux V, Salanoubat C, Farnault L, Guibaud I, Lamarque M, Gastaud L, Lemasle E, Brissot E, Tavernier E, Bilger K, Villate A, Soulier J, Graux C, Lheritier V, Dombret H, Boissel N, Clappier E
  Journal of Clinical Oncology · PubMed

• In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma
  Krug A, Saidane A, Martinello C, Fusil F, Michels A, Buchholz CJ, Ricci JE, Verhoeyen E
  Journal of Experimental & Clinical Cancer Research · PubMed

• Modeling HepaRG metabolome responses to pyrrolizidine alkaloid exposure for insight into points of departure and modes of action
  Dubreil E, Darney K, Delignette-Muller ML, Barranger A, Huet S, Hogeveen K, Leger T, Fessard V, Le Hegarat L
  Journal of Hazardous Materials · PubMed

• Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment
  Iacoboni G, Navarro V, Sesques P, Rejeski K, Bastos-Oreiro M, Serpenti F, Lopez AAM, Iraola-Truchuelo J, Delgado J, Perez A, Guerreiro M, Caballero AC, Martinez-Cibrian N, Henriquez HL, Pina JMS, Sancho JM, Ghesquieres H, Mussetti A, Corral LL, Hernani R, Reguera JL, Sureda A, Bosch F, Garcia-Sancho AM, Kwon M, Subklewe M, Kuhnl A, Bachy E, Barba P, Villacampa G, Abrisqueta P
  Journal of Hematology & Oncology · PubMed

• Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
  Sesques P, Kirkwood AA, Kwon M, Rejeski K, Jain MD, Di Blasi R, Brisou G, Gros FX, le Bras F, Bories P, Choquet S, Rubio MT, Iacoboni G, O’Reilly M, Casasnovas RO, Bay JO, Mohty M, Joris M, Abraham J, Llorente CC, Loschi M, Carras S, Chauchet A, La Rochelle LD, Hermine O, Guidez S, Cony-Makhoul P, Fogarty P, Le Gouill S, Morschhauser F, Gastinne T, Cartron G, Subklewe M, Locke FL, Sanderson R, Barba P, Houot R, Bachy E
  Journal of Hematology & Oncology · PubMed

• A Synthetic Circuit Empowering Reprogrammed B Cells for Therapeutic Proteins Expression Regulated by Tumor Detection
  Page A, Delles M, Negre D, Costa C, Fusil F, Cosset FL
  Journal of Immunotherapy · PubMed

• Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially associated with a particular subtype of Hodgkin’s lymphoma
  Peter E, Ciano-Petersen NL, Do L, Perrot J, Ngo T, Pluvinage J, Bartley CM, Zorn KC, Miske R, Scharf M, Villagran-Garcia M, Farina A, Rogemond V, Antoine JC, Tranchant C, Dubois V, Derisi JL, Pleasure SJ, Wilson MR, Gelfand JM, Traverse-Glehen A, Honnorat J, Desestret V
  Journal of Neurology · PubMed

• Integrated spatial and multimodal single-cell transcriptomics reveal patient-dependent cell heterogeneity in splenic marginal zone lymphoma
  Cerapio JP, Gravelle P, Quillet-Mary A, Valle C, Martins F, Franchini DM, Syrykh C, Brousset P, Traverse-Glehen A, Ysebaert L, Fournie JJ, Laurent C
  Journal of Pathology · PubMed

• Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
  Abramson JS, Ku M, Hertzberg M, Huang HQ, Fox CP, Zhang HL, Yoon DH, Kim WS, Abdulhaq H, Townsend W, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu YY, Cheah CY, Ghesquieres H, Simko S, Orellana-Noia V, Ta R, Relf J, Dixon M, Kallemeijn M, Mulvihill E, Huang H, Lundberg L, Gregory GP
  Lancet · PubMed

• Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
  Alcazer V, Le Meur G, Roccon M, Barriere S, Le Calvez B, Badaoui B, Spaeth A, Kosmider O, Freynet N, Eveillard M, Croizier C, Chevalier S, Sujobert P
  Lancet Digital Health · PubMed

• Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helperT-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
  Dupuis J, Bachy E, Morschhauser F, Cartron G, Fukuhara N, Daguindau N, Casasnovas RO, Snauwaert S, Gressin R, Fox CP, d’Amore FA, Staber PB, Tournilhac O, Bouabdallah K, Thieblemont C, Andre M, Rai S, Ennishi D, Gkasiamis A, Nishio M, Fornecker LM, Delfau-Larue MH, Sako N, Mule S, de Leval L, Gaulard P, Tsukasaki K, Lemonnier F
  Lancet Haematology · PubMed

• Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV-CHP?
  Julia E, Bachy E
  Lancet Haematology · PubMed

• Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
  Zinzani PL, Izutsu K, Mehta-Shah N, Barta SK, Ishitsuka K, Cordoba R, Kusumoto S, Bachy E, Cwynarski K, Gritti G, Prica A, Jacobsen E, Feldman T, Guillermin Y, Ennishi D, Yoon DH, Domenech ED, Zain J, Wang J, Kim JS, van der Poel M, Jin J, Wu ST, Chen Y, Moriyama T, Inoue A, Nakajima K, Horwitz SM
  Lancet Oncology · PubMed

• Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
  Wang ES, Issas GC, Erba HP, Altman JK, Montesinos P, Debotton S, Walter RB, Pettit K, Savona MR, Shah MV, Kremyanskaya M, Baer MR, Foran JM, Schiller G, Ades L, Heiblig M, Berthon C, Peterlin P, Rodriguez-Arboli E, Salamero O, Patnaik MM, Papayannidis C, Grembecka J, Cierpicki T, Clegg B, Ray J, Linhares BM, Nie K, Mitra A, Ahsan JM, Tabachri M, Soifer HS, Corum D, Leoni M, Dale S, Fathi A
  Lancet Oncology · PubMed

• Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
  Thieblemont C, Karimi YH, Ghesquieres H, Cheah CY, Clausen MR, Cunningham D, Jurczak W, Do YR, Gasiorowski R, Lewis DJ, Kim TM, van der Poel M, Poon ML, Feldman T, Linton KM, Sureda A, Hutchings M, Dinh MH, Kilavuz N, Soong D, Mark T, Sacchi M, Phillips T, Lugtenburg PJ
  Leukemia · PubMed

• Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
  Spanjaart AM, Ljungman P, Tridello G, Schwartz J, Martinez-Cibrian N, Barba P, Kwon M, Lopez-Corral L, Martinez-Lopez J, Ferra C, Di Blasi R, Ghesquieres H, Mutsaers P, Calkoen F, Jak M, van Doesum J, Vermaat JSP, van der Poel M, Maertens J, Gambella M, Metafuni E, Ciceri F, Saccardi R, Nicholson E, Tholouli E, Matthew C, Potter V, Bloor A, Besley C, Roddie C, Wilson K, Nagler A, Campos A, Petersen SL, Folber F, Bader P, Finke J, Kroger N, Knelange N, de la Camara R, Kersten MJ, Mielke S
  Leukemia · PubMed

• Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos
  Zala M, Lipinski B, Costechareyre C, Jarrosson L, Teinturier R, Julia E, Lacourrege M, Verney A, Guitton J, Traverse-Glehen A, Bachy E, Salles G, Huet S, Genestier L, Castellani V, Delloye-Bourgeois C, Sujobert P
  Leukemia · PubMed

• Real life evaluation of AlphaMissense predictions in hematological malignancies
  Chabane K, Charlot C, Gugenheim D, Simonet T, Armisen D, Viailly PJ, de Boisse GC, Huet S, Hayette S, Alcazer V, Sujobert P
  Leukemia · PubMed

• CAR T-cells in very elderly (=80 years) lymphoma patients: a DESCAR-T analysis
  Menez S, Bourbon E, Gounot R, Tudesq JJ, Moya N, Houot R, Bachy E
  Leukemia & Lymphoma · PubMed

• Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment
  Fouillet L, Daguenet E, Tavernier E, Ghesquieres H, Bachy E, Sesques P, Tournilhac O, Bay JO, Michallet AS, Sapet M, Chalayer E, Guyotat D, Tinquaut F, Cornillon J
  Leukemia & Lymphoma · PubMed

• A rapid progression from classical mantle cell lymphoma to a blastoid variant
  Chiriac R, Donzel M, Baseggio L
  Leukemia Research Reports · PubMed

• Histological characterization of liver involvement in systemic mastocytosis
  Rossignol J, Canioni D, Aouba A, Bulai-Livideanu C, Barete S, Lancesseur C, Polivka L, Madrange M, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Frenzel L, Meni C, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Pol S, Mallet V, Hermine O, Damaj G
  Liver International · PubMed

• Diagnostic staging and stratification in psychiatry and oncology: clarifying their conceptual, epistemological and ethical implications
  Tinland J, Gauld C, Sujobert P, Giroux E
  Medicine Health Care and Philosophy · PubMed

• Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
  Alig SK, Esfahani MS, Garofalo A, Li MY, Rossi C, Flerlage T, Flerlage JE, Adams R, Binkley MS, Shukla N, Jin MC, Olsen M, Telenius A, Mutter JA, Schroers-Martin JG, Sworder BJ, Rai S, King DA, Schultz A, Bogeholz J, Su SQ, Kathuria KR, Liu CL, Kang XM, Strohband MJ, Langfitt D, Pobre-Piza KF, Surman S, Tian F, Spina V, Tousseyn T, Buedts L, Hoppe R, Natkunam Y, Fornecker LM, Castellino SM, Advani R, Rossi D, Lynch R, Ghesquieres H, Casasnovas O, Kurtz DM, Marks LJ, Link MP, Andre M, Vandenberghe P, Steidl C, Diehn M, Alizadeh AA
  Nature · PubMed

• Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice
  Soudais C, Schaus R, Bachelet C, Minet N, Mouasni S, Garcin C, Souza CL, David P, Cousu C, Asnagli H, Parker A, Palmquist-Gomes P, Sepulveda FE, Storck S, Meilhac SM, Fischer A, Martin E, Latour S
  Nature Communications · PubMed

• Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
  Morschhauser F, Dahiya S, Palomba ML, Garcia-Sancho AM, Reguera-Ortega JL, Kuruvilla J, Jager U, Cartron G, Izutsu K, Dreyling M, Kahl B, Ghesquieres H, Ardeshna K, Goto H, Barbui AM, Abramson JS, Borchmann P, Fleury I, Mielke S, Skarbnik A, de Vos S, Kamdar M, Karmali R, Viardot A, Farazi T, Fasan O, Lymp J, Vedal M, Nishii R, Avilion A, Papuga J, Kumar J, Nastoupil LJ
  Nature Medicine · PubMed

• Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program
  Lattard C, Herledan C, Reverdy T, Antherieu G, Caffin AG, Cerfon MA, Maire M, Rivat M, France S, Ghesquieres H, You BN, Freyer G, Ranchon F, Rioufol C
  Oncologist · PubMed

• Regulus infers signed regulatory relations from few samples’ information using discretization and likelihood constraints
  Louarn M, Collet G, Barre E, Fest T, Dameron O, Siegel A, Chatonnet F
  Plos Computational Biology · PubMed

• Aflatoxin B1 and Epstein-Barr virus- induced CCL22 expression stimulates B cell infection
  Maroui MA, Odongo GA, Mundo L, Manara F, Mure F, Fusil F, Jay A, Gheit T, Michailidis TM, Ferrara D, Leoncini L, Murray P, Manet E, Ohlmann T, De Boevre M, De Saeger S, Cosset FL, Lazzi S, Accardi R, Herceg Z, Gruffat H, Khoueiry R
  Proceedings of the National Academy of Sciences of the United States of America · PubMed

• Interest of Regular Assays of Aqueous Humor Interleukin-10 Levels in Monitoring of Vitreoretinal Lymphoma
  Metayer C, Kodjikian L, Nguyen AM, Loria O, Chaperon M, Ghesquieres H, Mathis T
  Retina-the Journal of Retinal and Vitreous Diseases · PubMed

• Combined developmental exposure to estrogenic endocrine disruptor and nutritional imbalance induces long term adult prostate inflammation through inflammasome activation
  Gharieb K, Doumandji N, Bensalem W, Bellon RP, Inoubli L, Siddeek B, Traverse-Glehen A, Decaussin-Petrucci M, Trabucchi M, Benahmed M, Mauduit C
  Toxicology Letters · PubMed

• A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023
  Khanafer N, Oudot S, Maligeay M, Planckaert C, Mena C, Mandel NT, Bouhalila R, Ader F, Berard F, Bouhour F, Chapurlat R, Charriere S, Confavreux C, Devouassoux G, Disse E, Fouque D, Ghesquieres H, Hyvert S, Jolivot A, Durand A, Martin-Gaujard G, Mornex JF, Nicolino M, Andre-Obadia N, Raverot G, Reix P, Ruffion A, Seve P, Hermann R, Zoulim F, Clamens J, Ayala MP, Vanhems P
  Vaccine · PubMed

2023

• Chronic myelomonocytic leukemia transdifferentiation landscape: From histiocytosis to blastic plasmacytoid dendritic cell neoplasm
  Antherieu G, Donzel M, Balme B, Traverse-Glehen A, Heiblig M
  American Journal of Hematology · PubMed

• The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
  Rejeski K, Wang YC, Albanyan O, Munoz J, Sesques P, Iacoboni G, Lopez-Corral L, Ries I, Bucklein VL, Mohty R, Dreyling M, Baluch A, Shah BJ, Locke FL, Hess G, Barba P, Bachy E, Lin Y, Subklewe M, Jain MD
  American Journal of Hematology · PubMed

• Atlas of flow cytometry images: lymphoproliferative syndromes - Additional images obtained with DxFlex
  Harrivel V, Mayeur-Rousse C, Bouyer S, Baseggio L
  Annales De Biologie Clinique · PubMed

• Flow cytometry in chronic lymphproliferative disorders: report of a survey on practices on behalf of CytHem
  Mayeur-Rousse C, Bouyer S, Lesesve JF, Le Garff-Tavernier M, Baseggio L
  Annales De Biologie Clinique · PubMed

• Monoclonal B-cell lymphocytosis with a non-CLL immunophenotype-Review of 34 cases
  Heraud I, Mauduit C, Golfier C, Grange B, Baseggio L
  Annales De Biologie Clinique · PubMed

• Myeloma mimicking acute leukemia
  Mabrouk M, Baseggio L
  Annales De Biologie Clinique · PubMed

• Histoseminar of the French Society of Pathology “contribution of new molecular biology techniques in the diagnosis of lymphomas: myth or reality?”- Pre-Test
  Laurent C, Traverse-Glehen A, Xerri L, Charlotte S
  Annales De Pathologie · PubMed

• Histoseminar: “The contribution of new molecular biology techniques in the diagnosis of lymphoma: Myth or reality?”. Case 1: High grade B-cell lymphoma with 11q aberration
  Donzel M, Fontaine J, Traverse-Glehen A
  Annales De Pathologie · PubMed

• Histoseminar: “The contribution of new molecular biology techniques in the diagnosis of lymphoma: myth or
  Donzela M, Fontaine J, Traverse-Glehen A
  Annales De Pathologie · PubMed

• Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategies
  Trecourt A, Cottinet PJ, Donzel M, Favretto M, Bancel B, Decaussin-Petrucci M, Traverse-Glehen A, Devouassoux-Shisheboran M, Meyronet D, Belleannee G, Rullier A, Le MQ, Rival G, Grinberg D, Teap, EcoPath G
  Annals of Diagnostic Pathology · PubMed

• Sickle cell disease and acute leukemia: one case report and an extensive review
  Cannas G, Poutrel S, Heiblig M, Labussiere H, Larcher MV, Thomas X, Hot A
  Annals of Hematology · PubMed

• ASO Author Reflections: Redefining Consolidation Cytoreductive Surgery for Ovarian Cancer
  Bhatt A, Alcazer V, Frankinet L, Bakrin N, Glehen O
  Annals of Surgical Oncology · PubMed

• Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer
  Frankinet L, Bhatt A, Alcazer V, Classe JM, Bereder JM, Meeus P, Pomel C, Mithieux F, Abboud K, Wermert R, Lavoue V, Marchal F, Glehen O, Bakrin N
  Annals of Surgical Oncology · PubMed

• ASO Visual Abstract: Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer
  Frankinet L, Bhatt A, Alcazer V, Classe JM, Bereder JM, Meeus P, Pomel C, Mithieux F, Abboud K, Wermert R, Lavoue V, Marchal F, Glehen O, Bakrin N
  Annals of Surgical Oncology · PubMed

• Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
  Rejeski K, Subklewe M, Aljurf M, Bachy E, Balduzzi A, Barba P, Bruno B, Benjamin R, Carrabba MG, Chabannon C, Ciceri F, Corradini P, Delgado J, Di Blasi R, Greco R, Houot R, Iacoboni G, Jager U, Kersten MJ, Mielke S, Nagler A, Onida F, Peric Z, Roddie C, Ruggeri A, Sanchez-Guijo F, Sanchez-Ortega I, Schneidawind D, Schubert ML, Snowden JA, Thieblemont C, Topp M, Zinzani PL, Gribben JG, Bonini C, Sureda A, Yakoub-Agha I
  Blood · PubMed

• Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170
  Zinzani PL, Thieblemont C, Melnichenko V, Bouabdallah K, Walewski J, Majlis A, Fogliatto L, Garcia-Sancho AM, Christian B, Gulbas Z, Ozcan M, Perini GF, Ghesquieres H, Shipp MA, Thompson S, Chakraborty S, Marinello P, Armand P
  Blood · PubMed

• Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma
  Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Merin RD
  Blood · PubMed

• BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
  Delage L, Lambert M, Kundlacz C, Chartoire D, Conchon A, Gorka L, Auberger P, Jacquel A, Soussain C, Destaing O, Delecluse HJ, Delecluse S, Merabet S, Traverse-Glehen A, Salles G, Bachy E, Billaud M, Ghesqueres H, Rouaut JP, Sujobert P
  Blood · PubMed

• Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
  Lemoine J, Bachy E, Cartron G, Beauvais D, Gastinne T, Di Blasi R, Rubio MT, Guidez S, Mohty M, Casasnovas RO, Joris M, Castilla-Llorente C, Haioun C, Hermine O, Loschi M, Carras S, Bories P, Fradon T, Herbaux C, Sesques P, Le Gouil S, Morschhauser F, Thieblemont C, Houot R
  Blood Advances · PubMed

• LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
  Vasseur L, Fenwarth L, Lambert J, de Botton S, Figeac M, Villenet C, Heiblig M, Dumas PY, Recher C, Berthon C, Lemasle E, Lebon D, Lambert J, Terre C, Celli-Lebras K, Dombret H, Preudhomme C, Cheok M, Itzykson R, Duployez N
  Blood Advances · PubMed

• Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
  Bachy E, Savage KJ, Huang HQ, Kwong YL, Gritti G, Zhang QY, Liberati AM, Cao JN, Yang HY, Hao SG, Hu JD, Zhou KS, Petrini M, Russo F, Zhang HL, Sang W, Ji J, Ferreri AJM, Damaj GL, Liu H, Zhang W, Ke XY, Ghiggi C, Huang S, Li XT, Yao H, Paik J, Noveotny W, Zhou WX, Zhu HJ, Zinzani PL
  Blood Advances · PubMed

• Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia
  Tamburini J, Mouche S, Larrue C, Duployez N, Bidet A, Salotti A, Hirsch P, Rigolot L, Carras S, Temple M, Favale F, Flandrin-Gresta P, Le Bris Y, Alary AS, Mauvieux L, Tondeur S, Delabesse E, Delhommeau F, Sujobert P, Kosmider O
  Blood Advances · PubMed

• High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
  Camus V, Viailly PJ, Drieux F, Veresezan EL, Sesques P, Haioun C, Durot E, Patey M, Rossi C, Martin L, Rainville V, Bohers E, Ruminy P, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, Willaume A, Antier C, Lazarovici J, Leveque E, Decazes P, Becker S, Tonnelet D, Berriolo-Riedinger A, Gaulard P, Tilly H, Molina TJ, Traverse-Glehen A, Jardin F
  Blood Advances · PubMed

• Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
  Al Tabaa Y, Casasnovas RO, Baillet C, Bachy E, Nicolas-Virelizier E, Colella J, Bailly C, Kanoun S, Guidez S, Gyan E, Gressin R, Morineau N, Ysebaert L, Le Gouill S, Tilly H, Houot R, Morschhauser F, Cartron G, Herbaux C
  Blood Advances · PubMed

• HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
  Bourbon E, Sesques P, Gossez M, Tordo J, Ferrant E, Safar V, Wallet F, Aussedat G, Maarek A, Boua F, Karlin L, Ghergus D, Golfier C, Lequeu H, Lazareth A, Schwiertz V, Viel S, Idlhaj M, Ghesquieres H, Monneret G, Bachy E, Venet F
  Blood Advances · PubMed

• Low impact of polyploidization on the transcriptome of synthetic allohexaploid wheat
  Banouh M, Armisen D, Bouguennec A, Huneau C, Sow MD, Pont C, Salse J, Civan P
  Bmc Genomics · PubMed

• Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study
  Beldi-Ferchiou A, Jais JP, Ghesquieres H, Casasnovas RO, Tilly H, Fruchart C, Morschhauser F, Haioun C, Lazarovici J, Perrot A, Nicolas-Virelizier E, Salles G, Godard N, Zamali I, De Colella JMS, Claudel A, Corront B, Oberic L, Briere J, Gaulard P, Thieblemont C, Delfau-Larue MH
  British Journal of Haematology · PubMed

• Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen
  Laurent C, Flores M, Chartier L, Huet S, Bolen CR, Venstrom JM, Chassagne-Clement C, Dartigues-Cuilleres P, Charlotte F, Tesson B, Salles G, Morschhauser F, Xerri L
  British Journal of Haematology · PubMed

• Tandem haematopoietic stem cell transplantation versus single cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA
  Marouf A, Molinari N, Sibon D, Cottereau AS, Kanoun S, Antoine C, Debureaux PE, Cavalieri D, Fornecker LM, Casasnovas RO, Herbaux C, Amorim S, Rossi C, Bouscary D, Brice P, Ghesquieres H, Tamburini J, Deau B
  British Journal of Haematology · PubMed

• Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study
  Chaubard S, Marouf A, Lavergne D, Lemonnier F, Rossignol J, Clavert A, Gressin R, Cartron G, Waultier-Rascalou A, Vargaftig J, Salles G, Bachy E, Ghesquieres H, Tournilhac O, Chauchet A, Le Gouill S, Damaj G, Fornecker LM, Sibon D, Oberic L, Michot JM, Gaulard P, Hermine O, Couronne L, Jaccard A
  British Journal of Haematology · PubMed

• Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study
  Dulucq S, Rigal-Huguet F, Nicolini FE, Cony-Makhoul P, Escoffre-Barbe M, Gardembas M, Legros L, Rousselot P, Liu JX, Rea D, De Mas V, Hayette S, Raynaud S, Lacoste-Roussillon C, Robbesyn F, Klein E, Morisset S, Mahon FX, Etienne G
  British Journal of Haematology · PubMed

• C/EBPa Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia
  Sabatier M, Birsen R, Lauture L, Mouche S, Angelino P, Dehairs J, Goupille L, Boussaid I, Heiblig M, Boet E, Sahal A, Saland E, Santos JC, Armengol M, Fernandez-Serrano M, Farge T, Cognet G, Simonetta F, Pignon C, Graffeuil A, Mazzotti C, Avet-Loiseau H, Delos O, Bertrand-Michel J, Chedru A, Dembitz V, Gallipoli P, Anstee NS, Loo S, Wei AH, Carroll M, Goubard A, Castellano R, Collette Y, Vergez F, Mansat-De Mas V, Bertoli S, Tavitian S, Picard M, Recher C, Bourges-Abella N, Granat F, Kosmider O, Sujobert P, Colsch B, Joffre C, Stuani L, Swinnen JV, Guillou H, Roue G, Hakim N, Dejean AS, Tsantoulis P, Larrue C, Bouscary D, Tamburini J, Sarry JE
  Cancer Discovery · PubMed

• Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France
  Belhabri A, Heiblig M, Morisset S, Vila L, Santana C, Nicolas-Virelizier E, Hayette S, Tigaud I, Plesa A, Labussiere-Wallet H, Sobh M, Michallet AS, Marie B, Nicolini FE, Guillermin Y, Gaelle F, Lebras L, Rey P, Jauffret-Bertholon L, Laude MC, Sandrine L, Michallet M
  Cancer Medicine · PubMed

• Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia
  Calleja A, Loschi M, Bailly L, Morisot A, Marceau A, Mannone L, Robert G, Auberger P, Preudhomme C, Raynaud S, Subtil F, Sujobert P, Cluzeau T
  Cancer Medicine · PubMed

• Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas
  Donzel M, Pesce F, Trecourt A, Groussel R, Bachy E, Ghesquieres H, Fontaine J, Benzerdjeb N, Mauduit C, Traverse-Glehen A
  Cancers · PubMed

• Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
  Borie R, Debray MP, Guedon AF, Mekinian A, Terriou L, Lacombe V, Lazaro E, Meyer A, Mathian A, Ardois S, Vial G, Moulinet T, Terrier B, Jamilloux Y, Heiblig M, Bouaziz JD, Zakine E, Outh R, Groslerons S, Bigot A, Flamarion E, Kostine M, Henneton P, Humbert S, Constantin A, Samson M, Bertrand NM, Biscay P, Dieval C, Lobbes H, Jeannel J, Servettaz A, Adelaide L, Graveleau J, de Sainte-Marie B, Galland J, Guillotin V, Duroyon E, Temple M, Bourguiba R, Lavialle SG, Kosmider O, Audemard-Verger A
  Chest · PubMed

• Improving Diagnosis of Pulmonary Mucormycosis Leads From a Contemporary National Study of 114 Cases
  Coste A, Conrad A, Porcher R, Poiree S, Peterlin P, Defrance C, Letscher-Bru V, Morio F, Gastinne T, Bougnoux ME, Suarez F, Nevez G, Dupont D, Ader F, Halfon-Domenech C, Ducastelle-Lepretre S, Botterel F, Millon L, Guillerm G, Ansart S, Boutoille D, Ledoux MP, Herbrecht JE, Robin C, Melica G, Danion F, Blanchard E, Paccoud O, Garcia-Hermoso D, Lortholary O, Herbrecht R, Lanternier F
  Chest · PubMed

• B-cell malignancies and COVID-19: a narrative review
  Luque-Paz D, Sesques P, Wallet F, Bachy E, Ader F
  Clinical Microbiology and Infection · PubMed

• VEXAS: where do we stand 2 years later?
  Sujobert P, Heiblig M, Jamilloux Y
  Current Opinion in Hematology · PubMed

• Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database
  Antherieu G, Heiblig M, Freyer G, Ghesquieres H, Falandry C
  Drugs & Aging · PubMed

• Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514)
  Soussain C, Malaise D, Choquet S, Ghesquieres H, Houillier C
  European Journal of Cancer · PubMed

• VEXAS: is it time to reshape the nosology of clonal hematopoiesis?
  Sujobert P, Largeaud L, Jamilloux Y, Heiblig M, Kosmider O
  Expert Review of Hematology · PubMed

• Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome
  Veloza L, Cavalieri D, Missiaglia E, Ledoux-Pilon A, Bisig B, Pereira B, Bonnet C, Poullot E, Quintanilla-Martinez L, Dubois R, Llamas-Gutierrez F, Bossard C, De Wind R, Drieux F, Fontaine J, Parrens M, Sandrini J, Fataccioli V, Delfau-Larue MH, Daniel A, Lhomme F, Clement-Filliatre L, Lemonnier F, Cairoli A, Morel P, Glaisner S, Joly B, El Yamani A, Laribi K, Bachy E, Siebert R, Vallois D, Gaulard P, Tournilhac O, de Leval L
  Haematologica · PubMed

• Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
  Algrin C, Perol L, Chapiro E, Baseggio L, Maloum K, Settegrana C, Lesesve JF, Siavellis J, Delmer A, Michallet AS, Ferrant E, Feugier P, Tomowiak C, Brion A, Ghez D, Fornecker LM, Ivanoff S, Struski S, Sutton L, Radford-Weiss I, Eclache V, Lefebvre C, Leblond V, Nguyen-Khac F, Roos-Weil D
  Haematologica · PubMed

• Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
  Ghione P, Palomba ML, Ghesquieres H, Bobillo S, Patel AR, Nahas M, Kanters S, Deighton K, Hatswell A, Ma L, Oldfield EHL, Snider JT, Wade SW, Riberio MT, Radford J, Beygi S, Gribben J
  Haematologica · PubMed

• ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
  Sibon D, Bisig B, Bonnet C, Poullot E, Bachy E, Cavalieri D, Fataccioli V, Bregnard C, Drieux F, Bruneau J, Lemonnier F, Dupuy A, Bossard C, Parrens M, Bouabdallah K, Ketterer N, Berthod G, Cairoli A, Damaj G, Tournilhac O, Jais JP, Gaulard P, de Leval L
  Haematologica · PubMed

• Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients
  Walczak P, Choquet S, Dantal J, Boutboul D, Suarez F, Baron M, Morel V, Cluzeau T, Touati M, Elias M, Bachy E, Nicolas-Virelizier E, Houot R, Venton G, Jacquet C, Moles-Moreau MP, Jardin F, Durot E, Balegroune N, Ecotiere L, Guieze R, Kamar N, Ysebaert L, Couzi L, Gonzalez H, Roulin L, Ou KV, Caillard S, Zimmermann H, Trappe RU, Roos-Weil D
  Haematologica · PubMed

• KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma
  Decroos A, Cheminant M, Bruneau J, Carras S, Parinet V, Pelletier L, Lacroix L, Martin N, Giustiniani J, Lhermitte L, Asnafi V, Battistella M, Lemonnier F, de Leval L, Sicard H, Bonnafous C, Gauthier L, Genestier L, Caruso S, Gaulard P, Hermine O, Ortonne N
  Haematologica · PubMed

• Reporting From the First EHA Research Conference: Exciting Science With Panoramic Views
  Tesio M
  Hemasphere · PubMed

• Multiplying Preclinical Models for Multiple Myeloma
  Tesio M
  Hemasphere · PubMed

• Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome
  Faurel A, Heiblig M, Kosmider O, Cornillon J, Boudou L, Guyotat D, Jean-Alain M, Jamilloux Y, Noyel P, Daguenet E, Anne-Camille F, Sujobert P, Flandrin-Gresta P
  Hemasphere · PubMed

• Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France
  Darlington M, Sujobert P, Kosmider O, Paz DL, Kaltenbach S, Figeac M, Hayette S, Mezaour N, Coquerelle S, Alary AS, Bidet A, Le Bris Y, Delabesse E, Davi F, Preudhomme C, Durand-Zaleski I, Macintyre E
  Hemasphere · PubMed

• Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
  Rabut A, Jasserand L, Richard C, Dumas C, Mestrallet F, Bourbon E, Valentin MG, Heiblig M, Eveillard M, Jamilloux Y, Sujobert P
  Hemasphere · PubMed

• Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
  Tesio M
  Hemasphere · PubMed

• Sunscreen to Protect the Marrow
  Tesio M
  Hemasphere · PubMed

• Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
  Mozas P, Lopez C, Grau M, Nadeu F, Clot G, Valle S, Kulis M, Navarro A, Ramis-Zaldivar JE, Gonzalez-Farre B, Rivas-Delgado A, Rivero A, Frigola G, Balague O, Gine E, Delgado J, Villamor N, Matutes E, Magnano L, Garcia-Sanz R, Huet S, Russell RB, Campo E, Lopez-Guillermo A, Bea S
  Hematological Oncology · PubMed

• Atlas of flow cytometry images: Lymphoproliferative syndromes. Additional images obtained on DxFlex
  Harrivel V, Mayeur-Rousse C, Bouyer S, Baseggio L
  Hematologie · PubMed

• Modelisation et genomique pour la comprehension de la lymphomagenese
  Baseggio L, Bernard O
  Hematologie · PubMed

• The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots
  Lazarian G, Leroy B, Theves F, Hormi M, Letestu R, Eclache V, Tueur G, Ameur A, Bidet A, Cornillet-Lefebvre P, Davi F, Delabesse E, Estienne MH, Etancelin P, Kosmider O, Laibe S, Muller M, Nadal N, Naguib D, Pastoret C, Poulain S, Sujobert P, Veronese L, Imache S, Lefebvre V, Cymbalista F, Baran-Marszak F, Soussi T
  Human Mutation · PubMed

• Estimating the prevalence of Epstein-Barr virus in primary gastric lymphoma: a systematic review and meta-analysis
  Hirabayashi M, Traverse-Glehen A, Combes JD, Clifford GM, de Martel C
  Infectious Agents and Cancer · PubMed

• Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
  Berlanga P, Ndounga-Diakou LA, Aerts I, Corradini N, Ducassou S, Strullu M, de Carli E, Andre N, Entz-Werle N, Raimbault S, Roumy M, Renouard M, Gueguen G, Plantaz D, Reguerre Y, Cleirec M, Petit A, Puiseux C, Andry L, Klein S, Bodet D, Kanold J, Briandet C, Halfon-Domenech C, Nelken B, Piguet C, Saumet L, Chastagner P, Benadiba J, Millot F, Pluchart C, Schneider P, Thouvenin S, Gambart M, Serre J, Abbou S, Leruste A, Cayzac H, Gandemer V, Laghouati S, Vassal G
  Jama Network Open · PubMed

• Mortality and Associated Causes in Hemophagocytic Lymphohistiocytosis: A Multiple-Cause-of-Death Analysis in France
  La Marle S, Richard-Colmant G, Fauvernier M, Ghesquieres H, Hot A, Seve P, Jamilloux Y
  Journal of Clinical Medicine · PubMed

• Fungal Integrated Histomolecular Diagnosis Using Targeted Next-Generation Sequencing on Formalin-Fixed Paraffin-Embedded Tissues
  Trecourt A, Rabodonirina M, Mauduit C, Traverse-Glehen A, Devouassoux-Shisheboran M, Meyronet D, Dijoud F, Ginevra C, Chapey-Picq E, Josse E, Martins-Simoes P, Bentaher A, Dupont D, Miossec C, Persat F, Wallon M, Ferry T, Pham F, Simon B, Menotti J
  Journal of Clinical Microbiology · PubMed

• Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
  Cartron G, Bachy E, Tilly H, Daguindau N, Pica GM, Bijou F, Mounier C, Clavert A, Damaj GL, Slama B, Casasnovas O, Houot R, Bouabdallah K, Sibon D, Fitoussi O, Morineau N, Herbaux C, Gastinne T, Fornecker LM, Haioun C, Launay V, Araujo C, Benbrahim O, Sanhes L, Gressin R, Gonzalez H, Morschhauser F, Ternant D, Xerri L, Tarte K, Pranger D
  Journal of Clinical Oncology · PubMed

• Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial
  Fornecker LM, Lazarovici J, Aurer I, Casasnovas RO, Gac AC, Bonnet C, Bouabdallah K, Feugier P, Specht L, Molina L, Touati M, Borel C, Stamatoullas A, Nicolas-Virelizier E, Pascal L, Lugtenburg P, Di Renzo N, Vander Borght T, Traverse-Glehen A, Dartigues P, Hutchings M, Versari A, Meignan M, Federico M, Andre M
  Journal of Clinical Oncology · PubMed

• Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
  Thieblemont C, Phillips T, Ghesquieres H, Cheah CY, Clausen MR, Cunningham D, Do YR, Feldman T, Gasiorowski R, Jurczak W, Kim TM, Lewis DJ, van der Poel M, Poon ML, Stirner MC, Kilavuz N, Chiu C, Chen MH, Sacchi M, Elliott B, Ahmadi T, Hutchings M, Lugtenburg PJ
  Journal of Clinical Oncology · PubMed

• Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: A retrospective study
  Bernard J, Vacheron CH, Vantard N, Bachy E, Richard JC, Cour M, Lukaszewicz AC, Bohe J, Allaouchiche B, Friggeri A, Wallet F
  Journal of Critical Care · PubMed

• The Syriac World: In Search of a Forgotten Christianity
  Schmidt TC, Chatonnet F, Debie M
  Journal of Early Christian Studies · PubMed

• The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
  Rejeski K, Hansen DK, Bansal R, Sesques P, Ailawadhi S, Logue JM, Braeunlein E, dos Santos DMC, Freeman CL, Alsina M, Theurich S, Wang YC, Krackhardt AM, Locke FL, Bachy E, Jain MD, Lin Y, Subklewe M
  Journal of Hematology & Oncology · PubMed

• Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and-independent mechanisms
  Lucifora J, Alfaiate D, Pons C, Michelet M, Ramirez R, Fusil F, Amirache F, Rossi A, Legrand AF, Charles E, Vegna S, Farhat R, Rivoire M, Passot G, Gadot N, Testoni B, Bach C, Baumert TF, Hyrina A, Beran RK, Zoulim F, Boonstra A, Buning H, Verrier ER, Cosset FL, Fletcher SP, Salvetti A, Durantel D
  Journal of Hepatology · PubMed

• Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia
  Bourbon E, Chabane K, Mosnier I, Bouvard A, Thonier F, Ferrant E, Michallet AS, Poulain S, Hayette S, Sujobert P, Huet S
  Journal of Molecular Diagnostics · PubMed

• Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
  de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, d’Incan M, Ingen-Housz-Oro S, Orvain C, Abraham J, Dereure O, Charbonnier A, Cornillon J, Longvert C, Barete S, Boulinguez S, Wierzbicka-Hainaut E, Aubin F, Rubio MT, Bernard M, Schmidt-Tanguy A, Houot R, Pham-Ledard A, Michonneau D, Brice P, Labussiere-Wallet H, Bouaziz JD, Grange F, Moins-Teisserenc H, Jondeau K, Michel L, Mourah S, Battistella M, Daguindau E, Loschi M, Picard A, Franck N, Maillard N, Huynh A, Nguyen S, Marcais A, Chaby G, Ceballos P, Le Corre Y, Maury S, Bay JO, Adamski H, Bachy E, Forcade E, Socie G, Bagot M, Chevret S, de Latour RP
  Lancet · PubMed

• Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO
  Dumas PY, Raffoux E, Berard E, Bertoli S, Hospital MA, Heiblig M, Desbrosses Y, Bonmati C, Pautas C, Lambert J, Orvain C, Banos A, Pasquier F, Peterlin P, Marchand T, Uzunov M, Frayfer J, Turlure P, Cluzeau T, Jourdan E, Himberlin C, Tavernier E, Villate A, Haiat S, Chretien ML, Carre M, Chantepie S, Vaida I, Wemeau M, Chebrek S, Guillerm G, Guieze R, Debarri H, Gehlkopf E, Laribi K, Marcais A, Santagostino A, Bene MC, Mineur A, Pigneux A, Dombret H, Recher C
  Leukemia · PubMed

• Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing
  Armand M, Degaud M, Tesson B, Laurent C, Vavasseur M, Parisot M, Hoareau-Coudert B, Canioni D, Michot JM, Charlotte F, Meignin V, Laurent C, Traverse-Glehen A, Damotte D, Bachy E, Besson C, Hermine O, Davi F, Couronne L
  Leukemia · PubMed

• Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
  Bruch PM, Dietrich S, Finel H, Boumendil A, Greinix H, Heinicke T, Bethge W, Beelen D, Schmid C, Martin H, Castagna L, Scheid C, Schafer-Eckart K, Bittenbring J, Finke J, Sengeloev H, Heiblig M, Cornelissen J, Chevallier P, Mohty M, Robinson S, Montoto S, Dreger P
  Leukemia · PubMed

• Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
  Kuruvilla J, Armand P, Hamadani M, Kline J, Moskowitz CH, Avigan D, Brody JD, Ribrag V, Herrera AF, Morschhauser F, Kanate A, Zinzani PL, Bitran J, Ghesquieres H, Schuster SJ, Farooqui M, Marinello P, Bartlett NL
  Leukemia & Lymphoma · PubMed

• Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma
  Van Le H, Braun KV, Nowakowski GS, Sermer D, Radford J, Townsend W, Ghesquieres H, Menne T, Porpaczy E, Fox CP, Schusterbauer C, Liu FF, Yue LH, De Benedetti M, Hasskarl J
  Leukemia & Lymphoma · PubMed

• Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas
  Sortais C, Cordeil S, Bourbon E, Idlhaj M, Ferrant E, Safar V, Golfier C, Lazareth A, Bouafia-Sauvy F, Tordo J, Ghesquieres H, Sesques P, Bachy E
  Leukemia & Lymphoma · PubMed

• Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas
  Ribereau-Gayon E, Donzel M, Pham F, Romain-Scelle N, Perier-Muzet M, Balme B, Traverse-Glehen A, Ghesquieres H, Dalle S
  Leukemia & Lymphoma · PubMed

• Use of tamibarotene, a potent and selective RARa agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
  Stein EM, de Botton S, Cluzeau T, Pigneux A, Liesveld JL, Cook RJ, Rousselot P, Rizzieri DA, Braun T, Roboz GJ, Lebon D, Heiblig M, Baker K, Volkert A, Paul S, Rajagopal N, Roth DA, Kelly M, Peterlin P
  Leukemia & Lymphoma · PubMed

• First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia
  Balsat M, Alcazer V, Etienne G, Huguet F, Berger M, Cayssials E, Charbonnier A, Escoffre-Barbe M, Johnson-Ansah H, Legros L, Roy L, Delmer A, Ianotto JC, Orvain C, Larosa F, Meunier M, Ame S, Andreoli A, Cony-Makhoul P, Morisset S, Tigaud I, Rea D, Nicolini FE
  Leukemia Research · PubMed

• Preventable cancers: Is it enough to change our behaviour?
  Billaud M, Castets M, Trautmann A, Sujobert P
  M S-Medecine Sciences · PubMed

• Engineering B cells with customized therapeutic responses using a synthetic circuit
  Page A, Delles M, Negre D, Costa C, Fusil F, Cosset FL
  Molecular Therapy-Nucleic Acids · PubMed

• Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells
  Cousu C, Mulot E, De Smet A, Formichetti S, Lecoeuche D, Ren JK, Muegge K, Boulard M, Weill JC, Reynaud CA, Storck S
  Nature Communications · PubMed

• Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial
  Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Dulery R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F
  Nature Medicine · PubMed

• Tracing 100 million years of grass genome evolutionary plasticity
  Bellec A, Sow MD, Pont C, Civan P, Mardoc E, Duchemin W, Armisen D, Huneau C, Thevenin J, Vernoud V, Depege-Fargeix N, Maunas L, Escale B, Dubreucq B, Rogowsky P, Berges H, Salse J
  Plant Journal · PubMed

• From vacuoles to VEXAS
  Heiblig M, Sujobert P
  Rheumatology · PubMed

• Deciphering the spectrum of cutaneous lymphomas expressing TFH markers
  Donzel M, Trecourt A, Balme B, Harou O, Mauduit C, Bachy E, Guesquieres H, Fontaine J, Ortonne N, Perier-Muzet M, Dalle S, Traverse-Glehen A
  Scientific Reports · PubMed

• Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study
  Le Meur G, Plesa A, Larcher MV, Fossard G, Barraco F, Loron S, Balsat M, Ducastelle-Lepretre S, Gilis L, Thomas X, Ghesquieres H, Tigaud I, Hayette S, Huet S, Sujobert P, Renault M, Therese RM, Michallet M, Labussiere-Wallet H, Heiblig M
  Transplantation and Cellular Therapy · PubMed

• Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation
  Mouton W, Conrad A, Alcazer V, Boccard M, Bodinier M, Oriol G, Subtil F, Labussiere-Wallet H, Ducastelle-Lepretre S, Barraco F, Balsat M, Fossard G, Brengel-Pesce K, Ader F, Trouillet-Assant S
  Transplantation and Cellular Therapy · PubMed

2022

• Automatic Simplification of Scientific Texts: SimpleText Lab at CLEF-2022
  Ermakova L, Bellot P, Kamps J, Nurbakova D, Ovchinnikova I, SanJuan E, Mathurin E, Araujo S, Hannachi R, Huet S, Poinsu N
  Advances in Information Retrieval, Pt Ii · PubMed

• HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
  Alcazer V, Bonaventura P, Tonon L, Michel E, Mutez V, Fabres C, Chuvin N, Boulos R, Estornes Y, Maguer-Satta V, Geistlich K, Viari A, Metzeler KH, Hiddemann W, Batch AMN, Herold T, Caux C, Depil S
  American Journal of Hematology · PubMed

• TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
  Lazarian G, Theves F, Hormi M, Letestu R, Eclache V, Bidet A, Cornillet-Lefebvre P, Davi F, Delabesse E, Estienne MH, Etancelin P, Kosmider O, Laibe S, Lode L, Muller M, Nadal N, Naguib D, Pastoret C, Poulain S, Sujobert P, Veronese L, Imache S, Lefebvre V, Cymbalista F, Baran-Marszak F, Soussi T
  American Journal of Hematology · PubMed

• Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas A Series of 22 Cases Expanding the Spectrum of Transdifferentiation
  Trecourt A, Mauduit C, Szablewski V, Fontaine J, Balme B, Donzel M, Laurent C, Sesques P, Ghesquieres H, Bachy E, Salles G, Emile JF, Chassagne-Clement C, Genestier L, Copie-Bergman C, Traverse-Glehen A
  American Journal of Surgical Pathology · PubMed

• Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation
  Laurent C, Syrykh C, Hamon M, Adelaide J, Guille A, Escudie F, Jalowicki G, Fina F, Bardet A, Mescam L, Molina TJ, Dartigues P, Parrens M, Sujobert P, Besson C, Birnbaum D, Xerri L
  American Journal of Surgical Pathology · PubMed

• Lymphoma diagnosis: lessons learned from the comparison of histology and cytology associated with flow cytometry
  Aussedat G, Fontaine J, Gerland LM, Traverse-Glehen A, Baseggio L
  Annales De Biologie Clinique · PubMed

• Rosai-Dorfman-Destombes disease with a misleading laryngeal presentation
  Fiani DJ, Emile JF, Istier L, Boutin AB, Tychyj C, Benzerdjeb N, Donzel M, Balme B, Traverse-Glehen A, Fontaine J
  Annales De Pathologie · PubMed

• The upper ECHELON against T-cell lymphoma
  Bachy E, Salles G
  Annals of Oncology · PubMed

• KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target
  Cheminant M, Lhermitte L, Bruneau J, Sicard H, Bonnafous C, Touzart A, Bourbon E, Ortonne N, Genestier L, Gaulard P, Palmic P, Suarez F, Frenzel L, Naveau L, Bazarbachi A, Dussiot M, Waast L, Avettand-Fenoel V, Brouzes C, Pique C, Lepelletier Y, Asnafi V, Marcais A, Hermine O
  Blood · PubMed

• Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey
  Syrykh C, Chaouat C, Poullot E, Amara N, Fataccioli V, Parrens M, Traverse-Glehen A, Molina TJ, Xerri L, Martin L, Dubois R, Lacheretz-Szablewski V, Copin MC, Moreau A, Chenard MP, Cabarrou B, Lusque A, Gaulard P, Brousset P, Laurent C
  Blood · PubMed

• Genetic and phenotypic attributes of splenic marginal zone lymphoma
  Bonfiglio F, Bruscaggin A, Guidetti F, di Bergamo LT, Faderl M, Spina V, Condoluci A, Bonomini L, Forestieri G, Koch R, Piffaretti D, Pini K, Pirosa MC, Cittone MG, Arribas A, Lucioni M, Ghilardi G, Wu W, Arcaini L, Baptista MJ, Bastidas G, Bea S, Boldorini R, Broccoli A, Buehler MM, Canzonieri V, Cascione L, Ceriani L, Cogliatti S, Corradini P, Derenzini E, Devizzi L, Dietrich S, Elia AR, Facchetti F, Gaidano G, Garcia JF, Gerber B, Ghia P, da Silva MG, Gritti G, Guidetti A, Hitz F, Inghirami G, Ladetto M, Lopez-Guillermo A, Lucchini E, Maiorana A, Marasca R, Matutes E, Meignin V, Merli M, Moccia A, Mollejo M, Montalban C, Novak U, Oscier DG, Passamonti F, Piazza F, Pizzolitto S, Rambaldi A, Sabattini E, Salles G, Santambrogio E, Scarfo L, Stathis A, Stussi G, Geyer JT, Tapia G, Tarella C, Thieblemont C, Tousseyn T, Tucci A, Vanini G, Visco C, Vitolo U, Walewska R, Zaja F, Zenz T, Zinzani PL, Khiabanian H, Calcinotto A, Bertoni F, Bhagat G, Campo E, De Leval L, Dirnhofer S, Pileri SA, Piris MA, Traverse-Glehen A, Tzankov A, Paulli M, Ponzoni M, Mazzucchelli L, Cavalli F, Zucca E, Rossi D
  Blood · PubMed

• PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma
  Haas M, Caron G, Chatonnet F, Manenti S, Alaterre E, Devin J, Delaloy C, Bertolin G, Viel R, Pignarre A, Llamas-Gutierrez F, Marchalot A, Decaux O, Tarte K, Delpy L, Moreaux J, Fest T
  Blood · PubMed

• Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
  Bachy E, Houot R, Feugier P, Bouabdallah K, Bouabdallah R, Virelizier EN, Maerevoet M, Fruchart C, Snauwaert S, Le Gouill S, Marolleau JP, Molina L, Molucon-Chabrot C, Thieblemont C, Tilly H, Bijou F, Haioun C, Van den Neste E, Fabiani B, Meignan M, Cartron G, Salles G, Casasnovas O, Morschhauser F
  Blood · PubMed

• Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
  Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin YQ, Bryant B, Petrus MN, Bachy E, Huang DW, Yang YD, Green PL, Hasegawa H, Maeda M, Goto H, Endo T, Yokota T, Hatanaka KC, Hatanaka Y, Tanaka S, Matsuno Y, Yang YB, Hashino S, Teshima T, Waldmann TA, Staudt LM, Nakagawa M
  Blood · PubMed

• Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis
  Di Blasi R, Le Gouill S, Bachy E, Cartron G, Beauvais D, Le Bras F, Gros FX, Choquet S, Bories P, Feugier P, Casasnovas O, Bay JO, Mohty M, Joris M, Gastinne T, Sesques P, Tudesq JJ, Vercellino L, Morschhauser F, Gat E, Broussais F, Houot R, Thieblemont C
  Blood · PubMed

• Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
  Ghione P, Palomba ML, Patel AR, Bobillo S, Deighton K, Jacobson CA, Nahas M, Hatswell AJ, Jung AS, Kanters S, Snider JT, Neelapu SS, Ribeiro MT, Brookhart MA, Ghesquieres H, Radford J, Gribben JG
  Blood · PubMed

• Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
  Heiblig M, Ferrada MA, Koster MT, Barba T, Gerfaud-Valentin M, Mekinian A, Coelho H, Fossard G, Barraco F, Galicier L, Bienvenu B, Hirsch P, Vial G, Boutin AB, Galland J, Le Guenno G, Bigot A, Warrington KJ, Kermani TA, Grayson PC, Patel BA, Beck DB, Jamilloux Y, Fenaux P, Sujobert P
  Blood · PubMed

• Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
  Rejeski K, Burchert A, Iacoboni G, Sesques P, Fransecky L, Bucklein V, Trenker C, Hernani R, Naumann R, Schafer J, Blumenberg V, Schmidt C, Sohlbach K, von Bergwelt-Baildon M, Bachy E, Barba P, Subklewe M
  Blood Advances · PubMed

• Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial
  Camus V, Belot A, Oberic L, Sibon D, Ghesquieres H, Thieblemont C, Fruchart C, Casasnovas O, Michot JM, Molina TJ, Bosly A, Joubert C, Haioun C, Nicolas-Virelizier E, Feugier P, Fitoussi O, Delarue R, Tilly H
  Blood Advances · PubMed

• Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience
  Diarra A, Duployez N, Fournier E, Preudhomme C, Coiteux V, Magro L, Quesnel B, Heiblig M, Sujobert P, Barraco F, Balsat M, Scanvion Q, Hachulla E, Launay D, Yakoub-Agha I, Terriou L
  Blood Advances · PubMed

• Unusual peripheral T-cell lymphoma, displaying NOS and flower cells in the blood, and CNS involvement
  Gross Z, Baseggio L
  Blood Research · PubMed

• Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level
  Dussiau C, Boussaroque A, Gaillard M, Bravetti C, Zaroili L, Knosp C, Friedrich C, Asquier P, Willems L, Quint L, Bouscary D, Fontenay M, Espinasse T, Plesa A, Sujobert P, Gandrillon O, Kosmider O
  Bmc Biology · PubMed

• HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party
  Mikulska M, Penack O, Wendel L, Knelange N, Cornelissen JJ, Blijlevens N, Passweg J, Kroger N, Bruns A, Koenecke C, Bierings M, Pinana JL, Labussiere-Wallet H, Ghesquieres H, Diaz MA, Sampol A, Averbuch D, de la Camara R, Styczynski J
  Bone Marrow Transplantation · PubMed

• Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network
  Schenone L, Houillier C, Tanguy ML, Choquet S, Agbetiafa K, Ghesquieres H, Damaj G, Schmitt A, Bouabdallah K, Ahle G, Gressin R, Cornillon J, Houot R, Marolleau JP, Fornecker LM, Chinot O, Peyrade F, Bouabdallah R, Molucon-Chabrot C, Gyan E, Chauchet A, Casasnovas O, Oberic L, Delwail V, Abraham J, Roland V, Waultier-Rascalou A, Willems L, Morschhauser F, Fabbro M, Ursu R, Thieblemont C, Jardin F, Tempescul A, Malaise D, Touitou V, Nichelli L, Le Garff-Tavernier M, Plessier A, Bourget P, Bonmati C, Wantz-Mezieres S, Giordan Q, Dorvaux V, Charron C, Jabeur W, Hoang-Xuan K, Taillandier L, Soussain C
  Bone Marrow Transplantation · PubMed

• Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients
  Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, Lacombe, Terriou L, Ardois S, Bouaziz JD, Mathian A, Le Guenno G, Aouba A, Outh R, Meyer A, Roux-Sauvat M, Ebbo M, Zhao LP, Bigot A, Jamilloux Y, Guillotin, Flamarion E, Henneton P, Vial G, Jachiet, Rossignol J, Vinzio S, Weitten T, Vinit J, Deligny C, Humbert S, Samson M, Magy-Bertrand N, Moulinet T, Bourguiba R, Hanslik T, Bachmeyer C, Sebert M, Kostine M, Bienvenu B, Biscay P, Liozon E, Sailler L, Chasset F, Audemard-Verger A, Duroyon E, Sarrabay G, Borlot F, Dieval C, Cluzeau T, Marianetti P, Lobbes H, Boursier G, Gerfaud-Valentin M, Jeannel J, Servettaz A, Audia S, Larue M, Henriot B, Faucher B, Graveleau J, Sainte Marie B, Galland J, Bouillet L, Arnaud C, Ades L, Carrat F, Hirsch P, Fenaux P, Fain O, Sujobert P, Kosmider O, Mekinian A
  British Journal of Dermatology · PubMed

• Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
  Comont T, Heiblig M, Riviere E, Terriou L, Rossignol J, Bouscary D, Rieu V, Le Guenno G, Mathian A, Aouba A, Vinit J, Dion J, Kosmider O, Terrier B, Georgin-Lavialle S, Fenaux P, Mekinian A
  British Journal of Haematology · PubMed

• Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)
  Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R
  British Journal of Haematology · PubMed

• Nouvelles AMMs : cellules CAR-T Tisagenlecleucel et Axicabtagene ciloleucel - Lymphome folliculaire en troisieme et quatrieme ligne
  Cordeil S, Bachy E
  Bulletin Du Cancer · PubMed

• Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients
  Sesques P, Bachy E, Ferrant E, Safar V, Gossez M, Morfin-Sherpa F, Venet F, Ader F
  Cancer Cell · PubMed

• Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies
  Page A, Laurent E, Negre D, Costa C, Pierre V, Defrance T, Cosset FL, Fusil F
  Cancer Immunology Immunotherapy · PubMed

• Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study
  Bonnet A, Bossard C, Gabellier L, Rohmer J, Laghmari O, Parrens M, Sarkozy C, Dulery R, Roland V, Llamas-Gutierrez F, Oberic L, Fornecker LM, Bounaix L, Villemagne B, Szablewski V, Choquet S, Bouabdallah K, Traverse-Glehen A, Mohty M, Sanhes L, Houot R, Gastinne T, Leux C, Le Gouill S
  Cancer Medicine · PubMed

• Plasticity in Classical Hodgkin Composite Lymphomas: A Systematic Review
  Trecourt A, Donzel M, Fontaine J, Ghesquieres H, Jallade L, Antherieu G, Laurent C, Mauduit C, Traverse-Glehen A
  Cancers · PubMed

• Novel Targeted Therapies for T-Cell Malignancies
  Tesio M
  Cancers · PubMed

• Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
  Collomb B, Dubromel A, Caffin AG, Herledan C, Larbre V, Baudouin A, Cerutti A, Couturier L, Maire M, Karlin L, Maucort-Boulch D, Huot L, Dalle S, Bachy E, Ghesquieres H, Salles G, Couraud S, You BN, Freyer G, Trillet-Lenoir V, Ranchon F, Rioufol C
  Cancers · PubMed

• Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma
  Lamaison C, Ferrant J, Gravelle P, Traverse-Glehen A, Ghesquieres H, Tosolini M, Rossi C, Ysebaert L, Brousset P, Laurent C, Syrykh C
  Cancers · PubMed

• Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
  Bonnet C, Dupuis J, Tilly H, Lamy T, Fruchart C, le Gouill S, Thieblemont C, Morschhauser F, Casasnovas O, Bouabdallah K, Ghesquieres H, Van den Neste E, Andre M, Cartron G, Salles G
  Cancers · PubMed

• AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia
  Grenier A, Poulain L, Mondesir J, Jacquel A, Bosc C, Stuani L, Mouche S, Larrue C, Sahal A, Birsen R, Ghesquier V, Decroocq J, Mazed F, Lambert M, Andrianteranagna M, Viollet B, Auberger P, Lane AA, Sujobert P, Bouscary D, Sarry JE, Tamburini J
  Cell Reports · PubMed

• Genomics of the semi-aquatic bugs (Heteroptera; Gerromorpha): recent advances toward establishing a model lineage for the study of phenotypic evolution
  Armisen D, Khila A
  Current Opinion in Insect Science · PubMed

• Significance of Primary Melanoma Regression on Local Infiltrate and Outcome
  Kelati A, Balme B, Chouvet B, Traverse-Glehen A, Tantot J, Harou O, Duru G, Debarbieux S, Dalle S, Thomas L
  Dermatology Practical & Conceptual · PubMed

• Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas
  Revailler W, Cottereau AS, Rossi C, Noyelle R, Trouillard T, Morschhauser F, Casasnovas O, Thieblemont C, Le Gouill S, Andre M, Ghesquieres H, Ricci R, Meignan M, Kanoun S
  Diagnostics · PubMed

• Perls’ Stain Guidelines from the French-Speaking Cellular Hematology Group (GFHC)
  Lours C, Cottin L, Wiber M, Andrieu V, Baccini V, Baseggio L, Brouzes C, Chatelain B, Daliphard S, Fenneteau O, Genevieve F, Girard S, Leymarie V, Maloum K, Rieu JB, Sebahoun G, Sudaka I, Troussard X, Wagner-Ballon O, Wuilleme S, Bardet V, Lesesve JF
  Diagnostics · PubMed

• Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn’s Disease Activity: A Comparison with Surgical Histopathology Analysis
  Servais L, Boschetti G, Meunier C, Gay C, Cotte E, Francois Y, Rozieres A, Fontaine J, Cuminal L, Chauvenet M, Charlois AL, Isaac S, Traverse-Glehen A, Roblin X, Flourie B, Valette PJ, Nancey S
  Digestive Diseases and Sciences · PubMed

• Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France
  Donzel M, Bonjour M, Combes JD, Broussais F, Sesques P, Traverse-Glehen A, de Martel C
  Eclinicalmedicine · PubMed

• Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children
  Rudebeck CJ, Renard C, Halfon-Domenech C, Ouachee-Chardin M, Philippe M, Valla FV, Bertrand Y, Penel-Page M
  Ejhaem · PubMed

• Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy
  Mallet M, Boulos RE, Alcazer V, Bonaventura P, Estornes Y, Chuvin N, Depil S
  European Journal of Cancer · PubMed

• Overview of the CLEF 2022 SimpleText Lab: Automatic Simplification of Scientific Texts
  Ermakova L, SanJuan E, Kamps J, Huet S, Ovchinnikova I, Nurbakova D, Araujo S, Hannachi R, Mathurin E, Bellot P
  Experimental Ir Meets Multilinguality, Multimodality, and Interaction (Clef 2022) · PubMed

• Antibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trials
  Thomas X, Elhamri M, Deloire A, Heiblig M
  Expert Opinion on Emerging Drugs · PubMed

• The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose
  Luque-Paz D, Sesques P, Wallet F, Bachy E, Ader F
  Expert Review of Anti-Infective Therapy · PubMed

• Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
  Daull AM, Dubois V, Labussiere-Wallet H, Venet F, Barraco F, Ducastelle-Lepretre S, Larcher MV, Balsat M, Gilis L, Fossard G, Ghesquieres H, Heiblig M, Ader F, Alcazer V
  Frontiers in Immunology · PubMed

• A Simple-to-Perform ifn-? mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell Transplantation
  Boccard M, Conrad A, Mouton W, Valour F, Roure-Sobas C, Frobert E, Rohmer B, Alcazer V, Labussiere-Wallet H, Ghesquieres H, Venet F, Brengel-Pesce K, Trouillet-Assant S, Ader F
  Frontiers in Immunology · PubMed

• Mass cytometry analysis reveals attrition of naive and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients
  Andrieu T, Mondiere P, Jouve PE, Dussurgey S, Malassigne V, Servanton H, Baseggio L, Davi F, Michallet AS, Defrance T
  Frontiers in Oncology · PubMed

• Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
  Marouf A, Cottereau AS, Kanoun S, Deschamps P, Meignan M, Franchi P, Sibon D, Antoine C, Gastinne T, Borel C, Hammoud M, Sicard G, Gille R, Cavalieri D, Stamatoullas A, Filliatre-Clement L, Lazarovici J, Chauchet A, Fornecker LM, Amorin S, Rocquet M, Raus N, Burroni B, Rubio MT, Bouscary D, Quittet P, Casasnovas RO, Brice P, Ghesquieres H, Tamburini J, Deau B
  Haematologica · PubMed

• Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission
  Dulucq S, Hayette S, Cayuela JM, Bauduer F, Chabane K, Chevallier P, Cony-Makhoul P, Flandrin-Gresta P, Le Jeune C, Le Bris Y, Legros L, Maisonneuve H, Roy L, Mahon FX, Sloma I, Rea D, Nicolini FE
  Haematologica · PubMed

• Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning
  Cheli E, Chevalier S, Kosmider O, Eveillard M, Chapuis N, Plesa A, Heiblig M, Andre L, Pouget J, Mossuz P, Theisen O, Alcazer V, Gugenheim D, Autexier N, Sujobert P
  Haematologica · PubMed

• Mature T-cell neoplasms and stem cell transplant: the never-ending story
  Bachy E
  Haematologica · PubMed

• Bone Marrow Niches: Nests to Treat Anti-autoimmune Disorders?
  Tesio M
  Hemasphere · PubMed

• New Mechanisms of Genomic Escape From Noncovalent BTK Inhibitors
  Tesio M
  Hemasphere · PubMed

• Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study
  Younan N, Soussain C, Choquet S, Cassoux N, Touitou V, Schmitt A, Chinot O, Oberic L, Damaj G, Houot R, Ghesquieres H, Laribi K, Ahle G, Taillandier L, Paillassa JM, Gyan E, Jardin F, Delwail V, Marolleau JP, Tempescul A, Agape P, Bourniquel M, Vacheret F, Jdid I, Le Garff-Tavernier M, Malaise D, Alentorn A, Xuan KH, Houillier C
  Hematological Oncology · PubMed

• Human anti-smallpox long-lived memory B cells are defined by dynamic interactions in the splenic niche and long-lasting germinal center imprinting
  Chappert P, Huetz F, Espinasse MA, Chatonnet F, Pannetier L, Da Silva L, Goetz C, Megret J, Sokal A, Crickx E, Nemazanyy I, Jung V, Guerrera C, Storck S, Mahevas M, Cosma A, Revy P, Fest T, Reynaud CA, Weill JC
  Immunity · PubMed

• Gene signature of circulating platelet-bound neutrophils is associated with poor prognosis in cancer patients
  Lecot P, Ardin M, Dussurgey S, Alcazer V, Moudombi L, Abrantes MP, Hubert M, Swalduz A, Hernandez-Vargas H, Viari A, Caux C, Michallet MC
  International Journal of Cancer · PubMed

• Atypical extensive lupus tumidus-like eruption as an early presentation of VEXAS syndrome
  Ribereau-Gayon E, Heiblig M, Bourbon E, Sujobert P, Harou O, Theillac C, Poulalhon N, Balme B, Dalle S, Debarbieux S
  International Journal of Dermatology · PubMed

• Game of hands, theater under the deafness sign
  Bourbon E
  Jeu-Revue De Theatre · PubMed

• Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
  Trad R, Warda W, Alcazer V, da Rocha MN, Berceanu A, Nicod C, Haderbache R, Roussel X, Desbrosses Y, Daguindau E, Renosi F, Roumier C, Bouquet L, Biichle S, Guiot M, Seffar E, Caillot D, Depil S, Robinet E, Salma Y, Deconinck E, Deschamps M, Ferrand C
  Journal for Immunotherapy of Cancer · PubMed

• Improving reusability along the data life cycle: a regulatory circuits case study
  Louarn M, Chatonnet F, Garnier X, Fest T, Siegel A, Faron C, Dameron O
  Journal of Biomedical Semantics · PubMed

• Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
  Leclerc V, Karlin L, Herledan C, Marchal L, Baudouin A, Gouraud A, Caffin AG, Larbre, Lazareth A, Bachy E, Salles G, Ghesquieres H, Rioufol C, Ranchon F
  Journal of Cancer Research and Clinical Oncology · PubMed

• Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
  Morschhauser F, Nastoupil L, Feugier P, De Colella JMS, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, Garcia-Sancho AM, Lopez-Guillermo A, Larouche JF, Ando K, Da Silva MG, Andre M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G
  Journal of Clinical Oncology · PubMed

• Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
  Bachy E, Camus V, Thieblemont C, Sibon D, Casasnovas RO, Ysebaert L, Damaj G, Guidez S, Pica GM, Kim WS, Lim ST, Andre M, Garcia-Sancho AM, Penarrubia MJ, Staber PB, Trotman J, Huttmann A, Stefoni V, Re A, Gaulard P, Delfau-Larue MH, de Leval L, Meignan M, Li J, Morschhauser F, Delarue R
  Journal of Clinical Oncology · PubMed

• Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study
  Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Dupuis J, Gac AC, Gastinne T, Joly B, Bouabdallah K, Nicolas-Virelizier E, Feugier P, Morschhauser F, Sibon D, Bonnet C, Berriolo-Riedinger A, Edeline V, Parrens M, Damotte D, Coso D, Andre M, Meignan M, Rossi C
  Journal of Clinical Oncology · PubMed

• Panel Informativity Optimizer An R Package to Improve Cancer Next-Generation Sequencing Panel Informativity
  Alcazer V, Sujobert P
  Journal of Molecular Diagnostics · PubMed

• Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
  White HE, Salmon M, Albano F, Andersen CSA, Balabanov S, Balatzenko G, Barbany G, Cayuela JM, Cerveira N, Cochaux P, Colomer D, Coriu D, Diamond J, Dietz C, Dulucq S, Engvall M, Franke GN, Gineikiene-Valentine E, Gniot M, Gomez-Casares MT, Gottardi E, Hayden C, Hayette S, Hedblom A, Ilea A, Izzo B, Jimenez-Velasco A, Jurcek T, Kairisto V, Langabeer SE, Lion T, Meggyesi N, Mesanovic S, Mihok L, Mitterbauer-Hohendanner G, Moeckel S, Naumann N, Nibourel O, Leibundgut EO, Panayiotidis P, Podgornik H, Pott C, Rapado I, Rose SJ, Schafer V, Touloumenidou T, Veigaard C, Venniker-Punt B, Venturi C, Vigneri P, Vorkinn I, Wilkinson E, Zadro R, Zawada M, Zizkova H, Muller MC, Saussele S, Ernst T, Polakova KM, Hochhaus A, Cross NCP
  Leukemia · PubMed

• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
  Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBD, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao WB
  Leukemia · PubMed

• Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
  Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang ZM, Smedby KE, Kleinstern G, Hjalgrim H, Besson C, Skibola CF, Morton LM, Brooks-Wilson AR, Teras LR, Breeze C, Arias J, Adami HO, Albanes D, Anderson KC, Ansell SM, Bassig B, Becker N, Bhatti P, Birmann BM, Boffetta P, Bracci PM, Brennan P, Brown EE, Burdett L, Cannon-Albright LA, Chang ET, Chiu BCH, Chung CC, Clavel J, Cocco P, Colditz G, Conde L, Conti D, Cox DG, Curtin K, Casabonne D, De Vivo I, Diver WR, Dogan A, Edlund CK, Foretova L, Fraumeni JF, Gabbas A, Ghesquieres H, Giles GG, Glaser S, Glenn M, Glimelius B, Gu J, Habermann TM, Haiman CA, Haioun C, Hofmann JN, Holford TR, Holly EA, Hutchinson A, Izhar A, Jackson RD, Jarrett RF, Kaaks R, Kane E, Kolonel LN, Kong YF, Kraft P, Kricker A, Lake A, Lan Q, Lawrence C, Li DL, Liebow M, Link BK, Magnani C, Maynadie M, McKay J, Melbye M, Miligi L, Milne RL, Molina TJ, Monnereau A, Montalvan R, North KE, Novak AJ, Onel K, Purdue MP, Rand KA, Riboli E, Riby J, Roman E, Salles G, Sborov DW, Severson RK, Shanafelt TD, Smith MT, Smith A, Song KW, Song L, Southey MC, Spinelli JJ, Staines A, Stephens D, Sutherland HJ, Tkachuk K, Thompson CA, Tilly H, Tinker LF, Travis RC, Turner J, Vachon CM, Vajdic CM, Van den Berg A, Van den Berg DJ, Vermeulen RCH, Vineis P, Wang SS, Weiderpass E, Weiner GJ, Weinstein S, Doo NW, Ye YQ, Yeager M, Yu K, Zeleniuch-Jacquotte A, Zhang YW, Zheng TZ, Ziv E, Sampson J, Chatterjee N, Offit K, Cozen W, Wu XF, Cerhan JR, Chanock SJ, Slager SL, Rothman N
  Leukemia · PubMed

• Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group
  Fournier E, Heiblig M, Lespinasse C, Flandrin-Gresta P, Geay A, Miguet L, Fenwarth L, Vallat L, Soubeyrand B, Marceau-Renaut A, Plesa A, Preudhomme C, Sujobert P, Hayette S, Duployez N, Huet S
  Leukemia · PubMed

• Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study
  Aussedat G, Maucort-Boulch D, Rey P, Safar V, Karlin L, Elsensohn MH, Bachy E, Lebras L, Favier B, Vantard N, Ghergus D, Golfier C, Sesques P, Lazareth A, Lequeu H, Ferrant E, Salles G, Nicolas-Virelizier E, Ghesquieres H
  Leukemia & Lymphoma · PubMed

• Netrin-1 expression and targeting in multiple myeloma
  Fahed D, Chettab A, Mathe D, Denis M, Traverse-Glehen A, Karlin L, Perrial E, Dumontet C
  Leukemia & Lymphoma · PubMed

• Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
  Stamatoullas A, Ghesquieres H, Feugier P, Andre M, Le Bras F, Gac AC, Borel C, Gastinne T, Quittet P, Morschhauser F, Ribrag V, Guidez S, Nicolas-Virelizier E, Berriolo-Riedinger A, Vander Borght T, Edeline V, Brice P
  Leukemia & Lymphoma · PubMed

• Oncology and psychiatry For a fruitful reciprocal relationship
  Giroux E, Gansel Y, Basbous L, Tinland J, Sujobert P, Darrason M, Gauld C
  M S-Medecine Sciences · PubMed

• Investigations on the performance and the robustness of a metabsorber designed for structural vibration mitigation
  Bachy E, Jaboviste K, Sadoulet-Reboul E, Peyret N, Chevallier G, Arnould C, Collard E
  Mechanical Systems and Signal Processing · PubMed

• Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations
  Nicolae A, Bouilly J, Lara D, Fataccioli V, Lemonnier F, Drieux F, Parrens M, Robe C, Poullot E, Bisig B, Bossard C, Letourneau A, Missiaglia E, Bonnet C, Szablewski V, Traverse-Glehen A, Delfau-Larue MH, de Leval L, Gaulard P
  Modern Pathology · PubMed

• Transcriptome-based Phylogeny of the Semi-aquatic Bugs (Hemiptera: Heteroptera: Gerromorpha) Reveals Patterns of Lineage Expansion in a Series of New Adaptive Zones
  Armisen D, Viala S, Cordeiro IDS, Crumiere AJJ, Hendaoui E, Le Bouquin A, Duchemin W, Santos E, Toubiana W, Vargas-Lowman A, Floriano CFB, Polhemus DA, Wang YH, Rowe L, Moreira FFF, Khila A
  Molecular Biology and Evolution · PubMed

• Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
  Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Perez-Simon JA, Chen A, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Masood A, Anak O, Schuster SJ, Thieblemont C
  Nature Medicine · PubMed

• A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
  Bachy E, Le Gouill S, Di Blasi R, Sesques P, Manson G, Cartron G, Beauvais D, Roulin L, Gros FX, Rubio MT, Bories P, Bay JO, Llorente CC, Choquet S, Casasnovas RO, Mohty M, Guidez S, Joris M, Loschi M, Carras S, Abraham J, Chauchet A, La Rochelle LD, Deau-Fischer B, Hermine O, Gastinne T, Tudesq JJ, Gat E, Broussais F, Thieblemont C, Houot R, Morschhauser F
  Nature Medicine · PubMed

• Cerebellar Ataxia With Anti-DNER Antibodies Outcomes and Immunologic Features
  Peter E, Do L, Hannoun S, Muniz-Castrillo S, Vogrig A, Wucher V, Pinto AL, Chounlamountri N, Zakaria W, Rogemond V, Picard G, Hedou JJ, Ambati A, Alentorn A, Traverse-Glehen A, Manto M, Psimaras D, Mignot E, Cotton F, Desestret V, Honnorat J, Joubert B
  Neurology-Neuroimmunology & Neuroinflammation · PubMed

• Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
  Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, Kato K, Sureda A, Greil R, Thieblemont C, Morschhauser F, Janz M, Flinn, Rabitsch W, Kwong YL, Kersten MJ, Minnema MC, Holte H, Chan EHL, Martinez-Lopez J, Muller AMS, Maziarz RT, McGuirk JP, Bachy E, Le Gouill S, Dreyling M, Harigae H, Bond D, Andreadis C, McSweeney P, Kharfan-Dabaja M, Newsome S, Degtyarev E, Awasthi R, del Corral C, Andreola G, Masood A, Schuster SJ, Jager U, Borchmann P, Westin JR
  New England Journal of Medicine · PubMed

• Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  Dickinson MJ, Carlo-Stella C, Morschhauser F, Bachy E, Corradini P, Iacoboni G, Khan C, Wrobel T, Offner F, Wu SJ, Cartron G, Hertzberg M, Sureda A, Perez-Callejo D, Lundberg L, Relf J, Dixon M, Clark E, Humphrey K, Hutchings M, Trney M
  New England Journal of Medicine · PubMed

• Donor-Derived Leukemia in a Recipient of Double-Unit Cord Blood Transplantation for Acute Myeloid Leukemia: A Case Study and Literature Review
  Plesa A, Tigaud I, Hayette S, Roumier C, Thomas X
  Oncology and Therapy · PubMed

• Simulation of Outdoor Thermal Comfort: A Tweak with EnergyPlus Building Simulation 2021 Conference
  Walther E, Delmarre C, Huet S
  Proceedings of Building Simulation 2021: 17th Conference of Ibpsa · PubMed

• VEXAS syndrome-related AA amyloidosis: a case report
  Euvrard R, Fournier T, Georgescu D, Bourbon E, Sujobert P, Lega JC, Adelaide L
  Rheumatology · PubMed

• Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
  Bonaventura P, Alcazer V, Mutez V, Tonon L, Martin J, Chuvin N, Michel E, Boulos RE, Estornes Y, Valladeau-Guilemond J, Viari A, Wang Q, Caux C, Depil S
  Science Advances · PubMed

2021

• Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation
  Bachy E, Rufibach K, Parreira J, Launonen A, Nielsen T, Hackshaw A
  Advances in Therapy · PubMed

• HMGA1 induces EZH2 overexpression in human B-cell lymphomas
  De Martino M, Nicolau-Neto P, Pinto LFR, Traverse-Glehen A, Bachy E, Gigantino V, De Cecio R, Bertoni F, Chieffi P, Fusco A, Esposito F
  American Journal of Cancer Research · PubMed

• First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study
  Laude MC, Lebras L, Sesques P, Ghesquieres H, Favre S, Bouabdallah K, Croizier C, Guieze R, La Rochelle LD, Gyan E, Chin R, Aurran-Schleinitz T, Marouf A, Deau-Fischer B, Coppo P, Malot S, Roussel X, Chauchet A, Schwarz M, Bescond C, de la Chapelle TL, Bussot L, Carras S, Burlet B, Rossi C, Daniel A, Morschhauser F, Subtil F, Michallet AS
  American Journal of Hematology · PubMed

• Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
  Walter LP, Couronne L, Jais JP, Nguyen PD, Blaise D, Pigneux A, Socie G, Thieblemont C, Bachy E, Fegueux N, Chevallier P, Mohty M, Yakoub-Agha I, de Latour RP, Jaccard A, Hermine O
  American Journal of Hematology · PubMed

• Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study
  Lam M, Touitou V, Choquet S, Cassoux N, Ghesquieres H, Kodjikian L, Schmitt A, Gattoussi S, Tabouret E, Sampo M, Blonski M, Angioi-Duprez K, Houot R, Mouriaux F, Gyan E, Le Lez ML, Moles MP, Croise F, Chauchet A, Schwartz C, Ahle G, Meyer L, Gressin R, Chiquet C, Oberic L, Olle P, Marolleau JP, Jany B, Tempescul A, Cochener B, Damaj G, Quintyn JC, Molucon-Chabrot C, Rousseau E, Franciane P, Schneider C, Masse H, Tamburini-Bonnefoy JM, Brezin A, Fornecker LM, Ballonzoli L, Le Garff-Tavernier M, Hoang-Xuan K, Bodaghi B, Soussain C, Houillier C
  American Journal of Hematology · PubMed

• Relapsed / Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma
  Maurer MJ, Jakobsen LH, Mwangi R, Schmitz N, Farooq U, Flowers CR, Brown PD, Thompson CA, Frederiksen H, Cunningham D, Jorgensen J, Poeschel V, Nowakowski G, Seymour JF, Merli F, Haioun C, Ghesquieres H, Ziepert M, Tilly H, Salles G, Shi Q, El-Galaly TC, Habermann TM
  American Journal of Hematology · PubMed

• A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas
  Horn H, Kalmbach S, Wagener R, Staiger AM, Huttl K, Mottok A, Bens S, Traverse-Glehen A, Fontaine J, Siebert R, Rosenwald A, Ott G
  American Journal of Surgical Pathology · PubMed

• High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
  Laurent C, Adelaide J, Guille A, Tesson B, Gat E, Evrard S, Escudie F, Syrykh C, Canioni D, Fabiani B, Meignin V, Chassagne-Clement C, Dartigues P, Traverse-Glehen A, Parrens M, Huet S, Copie-Bergman C, Salles G, Birnbaum D, Brousset P, Morschhauser F, Xerri L
  American Journal of Surgical Pathology · PubMed

• Auer-rod like inclusions associated to azurophilic granules in plasma cells neoplasm
  Morin J, Baseggio L
  Annales De Biologie Clinique · PubMed

• Atlas of flow cytometry images: Lymphoproliferative syndromes
  Mayeur-Rousse C, Bouyer S, Baseggio L
  Annales De Biologie Clinique · PubMed

• Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
  Kim WS, Oki Y, Kim SJ, Yoon SE, Ardeshna KM, Lin Y, Ruan J, Porcu P, Brammer JE, Jacobsen ED, Yoon DH, Suh C, Suarez F, Radford J, Budde LE, Kim JS, Bachy E, Lee HJ, Bollard CM, Jaccard A, Kang HJ, Inman S, Murray M, Combs KE, Lee DIY, Advani R, Gunter KC, Rooney CM, Heslop HE
  Annals of Hematology · PubMed

• Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA
  Le Gouill S, Ghesquieres H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Maisonneuve H, Gressin R, Bouhabdallah K, Haioun C, Damaj G, Fornecker L, Bouhabdallah R, Feugier P, Sibon D, Cartron G, Bonnet C, Andre M, Chartier L, Ruminy P, Kraeber-Bodere F, Bodet-Milin C, Berriolo-Riedinger A, Briere J, Jais JP, Molina TJ, Itti E, Casasnovas RO
  Blood · PubMed

• Crystal-storing histiocytosis in Bing-Neel syndrome
  Dumas C, Baseggio L
  Blood · PubMed

• Plasmablasts derive from CD23- activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction
  Pignarre A, Chatonnet F, Caron G, Haas M, Desmots F, Fest T
  Blood · PubMed

• Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma
  Bolen CR, Mattiello F, Herold M, Hiddemann W, Huet S, Klapper W, Marcus R, Mir F, Salles G, Weigert O, Nielsen T, Oestergaard MZ, Venstrom JM
  Blood · PubMed

• A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia
  Fenwarth L, Thomas X, de Botton S, Duployez N, Bourhis JH, Lesieur A, Fortin G, Meslin PA, Yakoub-Agha I, Sujobert P, Dumas PY, Recher C, Lebon D, Berthon C, Michallet M, Pigneux A, Nguyen S, Chantepie S, Vey N, Raffoux E, Celli-Lebras K, Gardin C, Lambert J, Malfuson JV, Caillot D, Maury S, Ducourneau B, Turlure P, Lemasle E, Pautas C, Chevret S, Terre C, Boissel N, Socie G, Dombret H, Preudhomme C, Itzykson R
  Blood · PubMed

• Therapeutic options in VEXAS syndrome: insights from a retrospective series
  Bourbon E, Heiblig M, Valentin MG, Barba T, Durel CA, Lega JC, Barraco F, Seve P, Jamilloux Y, Sujobert P
  Blood · PubMed

• CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma
  Rejeski K, Perez A, Sesques P, Hoster E, Berger C, Jentzsch L, Mougiakakos D, Frolich L, Ackermann J, Bucklein V, Blumenberg V, Schmidt C, Jallades L, Fehse B, Faul C, Karschnia P, Weigert O, Dreyling M, Locke FL, von Bergwelt-Baildon M, Mackensen A, Bethge W, Ayuk F, Bachy E, Salles G, Jain MD, Subklewe M
  Blood · PubMed

• Mutational landscape of gray zone lymphoma
  Sarkozy C, Hung SS, Chavez EA, Duns G, Takata K, Chong LC, Aoki T, Jiang AX, Miyata-Takata T, Telenius A, Slack GW, Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A, Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW, Traverse-Glehen A, Steidl C
  Blood · PubMed

• Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP
  Bernard S, Ghesquieres H, Casasnovas RO, Griolet S, da Silva MG, Feugier P, Morschhauser F, Trotman J, Renaud L, Greil R, Garcia-Sancho AM, Grosicki S, van Eygen K, Copie-Bergman C, Haioun C, Thieblemont C
  Blood Advances · PubMed

• Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
  Paz DL, Riou J, Verger E, Cassinat B, Chauveau A, Ianotto JC, Dupriez B, Boyer F, Renard M, Mansier O, Murati A, Rey J, Etienne G, Mansat-De Mas V, Tavitian S, Nibourel O, Girault S, Le Bris Y, Girodon F, Ranta D, Chomel JC, Cony-Makhoul P, Sujobert P, Robles M, Ben Abdelali R, Kosmider O, Cottin L, Roy L, Sloma I, Vacheret F, Wemeau M, Mossuz P, Slama B, Cussac V, Denis G, Walter-Petrich A, Burroni B, Jezequel N, Giraudier S, Lippert E, Socie G, Kiladjian JJ, Ugo V
  Blood Advances · PubMed

• Early progression of disease in follicular lymphoma is a robust correlate but not a surrogate for overall survival
  Bachy E, Cerhan JR, Salles G
  Blood Advances · PubMed

• Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
  Lemonnier F, Safar V, Beldi-Ferchiou A, Cottereau AS, Bachy E, Cartron G, Fataccioli V, Pelletier L, Robe C, Letourneau A, Missiaglia E, Fourati S, Moles-Moreau MP, Delmer A, Bouabdallah R, Voillat L, Becker S, Bossard C, Parrens M, Casasnovas O, Cacheux V, Regny C, Camus V, Delfau-Larue MH, Meignan M, de Leval L, Gaulard P, Haioun C
  Blood Advances · PubMed

• Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
  Lambert J, Lambert J, Thomas X, Marceau-Renaut A, Micol JB, Renneville A, Clappier E, Hayette S, Recher C, Raffoux E, Pigneux A, Berthon C, Terre C, Celli-Lebras K, Castaigne S, Boissel N, Rousselot P, Preudhomme C, Dombret H, Duployez N
  Blood Advances · PubMed

• Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
  Camus V, Rossi C, Sesques P, Lequesne J, Tonnelet D, Haioun C, Durot E, Willaume A, Gauthier M, Moles-Moreau MP, Antier C, Lazarovici J, Monjanel H, Bernard S, Tardy M, Besson C, Lebras L, Choquet S, Le Du K, Bonnet C, Bailly S, Damaj G, Laribi K, Maisonneuve H, Houot R, Chauchet A, Jardin F, Traverse-Glehen A, Decazes P, Becker S, Berriolo-Riedinger A, Tilly H
  Blood Advances · PubMed

• Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified
  Bourbon E, Maucort-Boulch D, Fontaine J, Mauduit C, Sesques P, Safar V, Ferrant E, Golfier C, Ghergus D, Karlin L, Lazareth A, Bouafia F, Pica GM, Orsini-Piocelle F, Rocher C, Gros FX, Parrens M, Dony A, Rossi C, Ghesquieres H, Bachy E, Traverse-Glehen A, Sarkozy C
  Blood Advances · PubMed

• Lack of intrafollicular memory CD4+T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
  Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, Galkin I, Svelolkin V, Postovalova E, Bagaev A, Ovcharov P, Varlamova A, Huet S, Tesson B, McGrath KR, Slager S, Link BK, Syrbu S, Novak AJ, Habermann TM, Witzig TE, Nowakowski GS, Salles G, Cerhan JR, Ansell SM
  Blood Cancer Journal · PubMed

• Impact of male trait exaggeration on sex-biased gene expression and genome architecture in a water strider
  Toubiana W, Armisen D, Dechaud C, Arbore R, Khila A
  Bmc Biology · PubMed

• A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort
  Ghesquieres H, Rossi C, Cherblanc F, Le Guyader-Peyrou S, Bijou F, Sujobert P, Fabbro-Peray P, Bernier A, Belot A, Chartier L, Fornecker LM, Baldi I, Bouabdallah K, Laurent C, Oberic L, Morineau N, Le Gouill S, Morschhauser F, Haioun C, Damaj G, Guidez S, Laboure G, Fitoussi O, Lebras L, Gressin R, Salles G, Ysebaert L, Monnereau A
  Bmc Public Health · PubMed

• Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT
  Eyre TA, Caillard S, Finel H, Boumendil A, Kothari J, Zimmermann H, Trappe RU, De Wilde V, Tholouli E, Kanfer E, Broom A, Damaj G, Bargetzi M, Kozak T, Hilgendorf I, Crawley C, Kerre T, Trneny M, Bachy E, Robinson S, Montoto S
  Bone Marrow Transplantation · PubMed

• BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres
  Ghesquieres H, Dalban C, Nicolas-Virelizier E, Jardin F, Le Bras F, Le Gouill S, Casasnovas O, Vizoso S, Hernandez C, Metzger S, Perol D, Cartron G
  British Journal of Haematology · PubMed

• Real-life targeted next-generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network
  Bommier CM, Mauduit C, Fontaine J, Bourbon E, Sujobert P, Huet S, Baseggio L, Hayette S, Laurent C, Bachy E, Ghesquieres H, Thieblemont C, Salles G, Traverse-Glehen A
  British Journal of Haematology · PubMed

• Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies
  Bussot L, Chevalier S, Cristante J, Grange B, Tesson B, Deteix-Santana C, Orsini-Piocelle F, Leyronnas C, Dupire S, Gressin R, Salles G, Bachy E, Emadali A, Valmary-Degano S, Huet S, Lefebvre C, Carras S
  British Journal of Haematology · PubMed

• Eligibility of patients for CAR T-cell: Expert opinion-based collaborative work by the SFGM-TC
  Beauvais D, Bachy E, Baruchel A, Bay JO, Caillot D, Cartron G, Damaj G, Furst S, Le Gouill S, Morschhauser F, Rabian F, Rubio MT, Thieblemont C, Yakoub-Agha I
  Bulletin Du Cancer · PubMed

• Development of allogeneic CAR T-cells
  Alcazer V, Depil S
  Bulletin Du Cancer · PubMed

• COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
  Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, Halfon-Domenech C, Leblanc T, Leverger G, Michel G, Petit A, Ray-Lunven AF, Rohrlich PS, Schneider P, Sirvent N, Strullu M, Baruchel A
  Bulletin Du Cancer · PubMed

• CAR-T cell: Toxicities issues: Mechanisms and clinical management
  Wallet F, Sesques P, Devic P, Levrard M, Ader F, Friggeri A, Bachy E
  Bulletin Du Cancer · PubMed

• CAR-T cells, from principle to clinical applications
  Bourbon E, Ghesquieres H, Bachy E
  Bulletin Du Cancer · PubMed

• COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
  Peron J, Dagonneau T, Conrad A, Pineau F, Calattini S, Freyer G, Perol D, Sajous C, Heiblig M
  Cancers · PubMed

• Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication
  Antherieu G, Bidet A, Huet S, Hayette S, Migeon M, Boureau L, Sujobert P, Thomas X, Ghesquieres H, Pigneux A, Heiblig M
  Cancers · PubMed

• Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
  Jullien M, Tessoulin B, Ghesquieres H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Villemagne B, Gressin R, Bouabdallah K, Haioun C, Damaj G, Fornecker LM, De Colella JMS, Feugier P, Hermine O, Cartron G, Bonnet C, Andre M, Bailly C, Casasnovas RO, Le Gouill S
  Cancers · PubMed

• The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
  Heiblig M, Duployez N, Marceau A, Lebon D, Goursaud L, Plantier I, Stalnikiewich L, Cambier N, Balsat M, Fossard G, Labussiere-Wallet H, Barraco F, Ducastelle-Lepretre S, Sujobert P, Huet S, Hayette S, Ghesquieres H, Thomas X, Preudhomme C
  Cancers · PubMed

• Zeb1 represses TCR signaling, promotes the proliferation of T cell progenitors and is essential for NK1.1+ T cell development
  Zhang J, Wencker M, Marliac Q, Berton A, Hasan U, Schneider R, Laubreton D, Cherrier DE, Mathieu AL, Rey A, Jiang WZ, Caramel J, Genestier L, Marcais A, Marvel J, Ghavi-Helm Y, Walzer T
  Cellular & Molecular Immunology · PubMed

• Intravenous immunoglobulins: an eye opener on the successful treatment of severe adult-onset paraprotein-associated xanthogranulomatosis
  Bergqvist C, Bernigaud C, Ingen-Housz-Oro S, Sujobert P, Hotz C, Lebre C, Ortonne N, Chosidow O
  Clinical and Experimental Dermatology · PubMed

• Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function
  Ruggiero C, Altieri B, Arnold E, Siqueiros-Marquez L, Doghman-Bouguerra M, Detomas M, Durand N, Jarjat M, Kurlbaum M, Chatonnet F, Deutschbein T, Clapp C, Lalli E
  Clinical and Translational Medicine · PubMed

• Crystal-storing histiocytosis and Bing-Neel-like syndrome revealing a small B-cell lymphoma with plasmacytic differentiation, presumed to be a marginal zone lymphoma
  Lequain H, Gerfaud-Valentin M, Fontaine J, Ferrant E, Grumet P, Jamilloux Y, Traverse-Glehen A, Seve P
  Clinical Case Reports · PubMed

• Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
  Sesques P, Tordo J, Ferrant E, Safar V, Wallet F, Dhomps A, Brisou G, Bouafia F, Karlin L, Ghergus D, Golfier C, Lequeu H, Lazareth A, Vercasson M, Hospital-Gustem C, Schwiertz V, Choquet M, Sujobert P, Novelli S, Mialou V, Hequet O, Carras S, Fouillet L, Lebras L, Guillermin Y, Leyronnas C, Cavalieri D, Janier M, Ghesquieres H, Salles G, Bachy E
  Clinical Nuclear Medicine · PubMed

• New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas
  Donzel M, Baseggio L, Fontaine J, Pesce F, Ghesquieres H, Bachy E, Verney A, Traverse-Glehen A
  Current Oncology · PubMed

• Entropy as a measure of variability and sternness in single-cell transcriptomics
  Gandrillon O, Gaillardt M, Espinasse T, Garnier NB, Dussiau C, Kosmider O, Sujobert P
  Current Opinion in Systems Biology · PubMed

• MulticentricMFI30study: Standardization of flow cytometry analysis ofCD30expression innon-Hodgkinlymphoma
  Debliquis A, Baseggio L, Bouyer S, Guy J, Garnache-Ottou F, Genevieve F, Mayeur-Rousse C, Letestu R, Chapuis N, Harrivel V, Bennani H, Lachot S, Loosveld M, Nicolino-Brunet C, Peres M, Roussel M, Veyrat-Masson R, Jacob MC, Drenou B
  Cytometry Part B-Clinical Cytometry · PubMed

• A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process
  Perez-Vargas J, Teppa E, Amirache F, Boson B, de Oliveira RP, Combet C, Bockmann A, Fusil F, Freitas N, Carbone A, Cosset FL
  Elife · PubMed

• Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies
  Koeppel F, Muller E, Harle A, Guien C, Sujobert P, Grati OT, Kosmider O, Miguet L, Mauvieux L, Cayre A, Salgado D, Preudhomme C, Karayan-Tapon L, Tachon G, Coulet F, Lespagnol A, Beroud C, Leroy K, Rouleau E, Soubeyran I
  European Journal of Cancer · PubMed

• An EBV-positive mucocutaneous ulcer in an unusual location with a surprising evolution
  Donzel M, Neyrand S, Skowron F, Balme B, Traverse-Glehen A
  European Journal of Dermatology · PubMed

• Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
  Manson G, Brice P, Herbaux C, Silva MG, Bouabdallah K, Deau B, Bouteloup J, Schiano JM, Nicolas-Virelizier E, Maerevoet M, Ghesquieres H, Stamatoullas A, Antier C, Carlo-Stella C, de Charette M, Poizeau F, Dercle L, Houot R
  European Journal of Nuclear Medicine and Molecular Imaging · PubMed

• Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
  Salles G, Dlugosz-Danecka M, Ghesquieres H, Jurczak W
  Expert Opinion on Biological Therapy · PubMed

• Obesity activates immunomodulating properties of mesenchymal stem cells in adipose tissue with differences between localizations
  Lefevre C, Chartoire D, Ferraz JC, Verdier T, Pinteur C, Chanon S, Pesenti S, Vieille-Marchiset A, Genestier L, Vidal H, Mey A
  Faseb Journal · PubMed

• Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells
  Gutierrez-Guerrero A, Recalde MJA, Mangeot PE, Costa C, Bernadin O, Perian S, Fusil F, Froment G, Martinez-Turtos A, Krug A, Martin F, Benabdellah K, Ricci EP, Giovannozzi S, Gijsbers R, Ayuso E, Cosset FL, Verhoeyen E
  Frontiers in Genome Editing · PubMed

• Early Emergence of Adaptive Mechanisms Sustaining Ig Production: Application to Antibody Therapy
  Lemarie M, Chatonnet F, Caron G, Fest T
  Frontiers in Immunology · PubMed

• Committed Human CD23-Negative Light-Zone Germinal Center B Cells Delineate Transcriptional Program Supporting Plasma Cell Differentiation
  Santamaria K, Desmots F, Leonard S, Caron G, Haas M, Delaloy C, Chatonnet F, Rossille D, Pignarre A, Monvoisin C, Seffals M, Lamaison C, Cogne M, Tarte K, Fest T
  Frontiers in Immunology · PubMed

• EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma
  Julia E, Salles G
  Future Oncology · PubMed

• How to Transform an Exceptional Case Report Into a Therapy: Following the Frog Out of the Box
  Heiblig M, Alcazer V, Plesa A, Labussiere-Wallet H, Sujobert P
  Hemasphere · PubMed

• Stemness and Relapse: “Chicken or the Egg” Question
  Tesio M
  Hemasphere · PubMed

• Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies
  Hayette S, Grange B, Vallee M, Bardel C, Huet S, Mosnier I, Chabane K, Simonet T, Balsat M, Heiblig M, Tigaud I, Nicolini FE, Mareschal S, Salles G, Sujobert P
  Hemasphere · PubMed

• Enhancing Leukemia Taxonomy
  Tesio M
  Hemasphere · PubMed

• Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience
  Alary AS, Maute C, Kosmider O, Sujobert P, Gauthier A, Macintyre E, Preudhomme C, Hayette S, Luque-Paz D, Baran-Marszak F, Davi F, Lippert E, Cornillet-Lefebvre P, Delfau-Larue MH, Cassinat B, Cayuela JM, Flandrin-Gresta P
  Hemasphere · PubMed

• tiRNA Join Hematopoietic Niches
  Tesio M
  Hemasphere · PubMed

• Deep Multi-lnstance Learning Using Multi-Modal Data for Diagnosis for Lymphocytosis
  Sahasrabudhe M, Sujobert P, Zacharaki E, Maurin E, Grange B, Jallades L, Paragios N, Vakalopoulou M
  Ieee Journal of Biomedical and Health Informatics · PubMed

• Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape
  Mourcin F, Verdiere L, Roulois D, Amin R, Lamaison C, Sibut V, Thamphya B, Pangault C, Monvoisin C, Huet S, Seffals M, Baulande S, Mechta-Grigoriou F, Legoix P, Rossille D, Guirriec M, Leonard S, Cartron G, Salles G, Fest T, Tarte K
  Immunity · PubMed

• The structural parameters and flags of the Sysmex XN™ analyser: Are they discriminative between reactive and malignant lymphocytosis in the context of lymphocyte counts above 5 x 109/L in adults?
  Cornet E, Comte E, Baseggio L
  International Journal of Laboratory Hematology · PubMed

• Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors
  Page A, Hubert J, Fusil F, Cosset FL
  International Journal of Molecular Sciences · PubMed

• Decentralizing theatre
  Bourbon E
  Jeu-Revue De Theatre · PubMed

• Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production
  Lucifora J, Pastor F, Charles E, Pons C, Auclair H, Fusil F, Rivoire M, Cosset FL, Durantel D, Salvetti A
  Jhep Reports · PubMed

• Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and future
  Page A, Fusil F, Cosset FL
  Joint Bone Spine · PubMed

• Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming
  Carras S, Chartoire D, Mareschal S, Heiblig M, Marcais A, Robinot R, Urb M, Pommier RM, Julia E, Chebel A, Verney A, Bertheau C, Bardel E, Fezelot C, Courtois L, Lours C, Bouska A, Sharma S, Lefebvre C, Rouault JP, Sibon D, Ferrari A, Iqbal J, de Leval L, Gaulard P, Traverse-Glehen A, Sujobert P, Blery M, Salles G, Walzer T, Bachy E, Genestier L
  Journal of Clinical Investigation · PubMed

• Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
  Demeestere I, Racape J, Dechene J, Dupuis J, Morschhauser F, De Wilde V, Lazarovici J, Ghesquieres H, Touati M, Sibon D, Alexis M, Gac AC, Moatti H, Virelizier E, Maisonneuve H, Pranger D, Houot R, Fornecker LM, Tempescul A, Andre M, Casasnovas RO
  Journal of Clinical Oncology · PubMed

• Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients
  Haderbache R, Warda W, Hervouet E, da Rocha MN, Trad R, Allain V, Nicod C, Thieblemeont C, Boissel N, Varlet P, Agha IY, Bouquet L, Guiot M, Venet F, Sujobert P, Roussel X, Rouzaire PO, Caillot D, Casasnovas O, Bories JC, Bachy E, Caillat-Zucman S, Deschamps M, Ferrand C
  Journal of Translational Medicine · PubMed

• Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy
  Cerrano M, Duchmann M, Kim R, Vasseur L, Hirsch P, Thomas X, Quentin S, Pasanisi J, Passet M, Rabian F, Rahme R, Lengline E, Raffoux E, Dhedin N, Sebert M, Maarek O, Raimbault A, Celli-Lebras K, Ades L, Fenaux P, Boissel N, Delhommeau F, Soulier J, Dombret H, Clappier E, Sujobert P, Itzykson R
  Leukemia · PubMed

• Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia
  Letestu R, Dahmani A, Boubaya M, Baseggio L, Campos L, Chatelain B, Debliquis A, Drenou B, Jacob MC, Legac E, Le Garff-Tavernier M, Lhoumeau AC, Quiney C, Robillard N, Ticchioni M, Aanei C, Katsahian S, Delepine R, Vaudaux S, Rouille V, Bene MC, Dartigeas C, van den Neste E, Lepretre S, Feugier P, Cartron G, Leblond V, Levy V, Cymbalista F
  Leukemia · PubMed

• Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
  Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, Barba P, Kwon M, Caballero D, Sesques P, Bachy E, Di Blasi R, Thieblemont C, Calkoen F, Mutsaers P, Maertens J, Giannoni L, Nicholson E, Collin M, Vaz CP, Metafuni E, Martinez-Lopez J, Dignan FL, Ribera JM, Nagler A, Folber F, Sanderson R, Bloor A, Ciceri F, Knelange N, Ayuk F, Kroger N, Kersten MJ, Mielke S
  Leukemia · PubMed

• Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia
  Yurkiewicz IR, Coutre S, Ghesquieres H, Pastan I, Kreitman RJ
  Leukemia & Lymphoma · PubMed

• Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry
  Plesa A, Roumier C, Gutrin J, Larcher MV, Balsat M, Cadassou O, Barraco F, Fossard G, Baudouin A, Labussiere H, Tigaud I, Ducastelle S, Hayette S, Sujobert P, Heiblig M, Elhamri M, Thomas X
  Leukemia Research · PubMed

• Genetic in vivo engineering of human T lymphocytes in mouse models
  Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J, Verhoeyen E, Buchholz CJ
  Nature Protocols · PubMed

• How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks
  Bourbon E, Alcazer V, Cheli E, Huet S, Sujobert P
  Pharmaceuticals · PubMed

• The growth factor BMP11 is required for the development and evolution of a male exaggerated weapon and its associated fighting behavior in a water strider
  Toubiana W, Armisen D, Viala S, Decaras A, Khila A
  Plos Biology · PubMed

• VEXAS syndrome in a woman
  Barba T, Jamilloux Y, Durel CA, Bourbon E, Mestrallet F, Sujobert P, Hot A
  Rheumatology · PubMed

• Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis
  Villani AP, Rozieres A, Bensaid B, Eriksson KK, Mosnier A, Albert F, Mutez V, Brassard O, Baysal T, Tardieu M, Allatif O, Fusil F, Andrieu T, Jullien D, Dubois V, Giannoli C, Gruffat H, Pallardy M, Cosset FL, Nosbaum A, Kanagawa O, Maryanski JL, Yerly D, Nicolas JF, Vocanson M
  Science Advances · PubMed

• Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia
  Crickx E, Chappert P, Sokal A, Weller S, Azzaoui I, Vandenberghe A, Bonnard G, Rossi G, Fadeev T, Storck S, Fadlallah J, Meignin V, Riviere E, Audia S, Godeau B, Michel M, Weill JC, Reynaud CA, Mahevas M
  Science Translational Medicine · PubMed

• Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
  Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, Lambert E
  Scientific Reports · PubMed

• Toward a pathophysiology inspired treatment of VEXAS syndrome
  Heiblig M, Patel BA, Groarke EM, Bourbon E, Sujobert P
  Seminars in Hematology · PubMed

• T- and B-cell therapy in solid organ transplantation: current evidence and future expectations
  Pilat N, Lefsihane K, Brouard S, Kotsch K, Falk C, Steiner R, Thaunat O, Fusil F, Montserrat N, Amarelli C, Casiraghi F
  Transplant International · PubMed

• Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study
  Barba T, Bachy E, Maarek A, Fossard G, Genestier L, Anglicheau D, Moal V, Dantal J, Rieu P, Chemouny J, Charrier M, Durrbach A, Provot F, Ducloux D, Westeel PF, Heng AE, Rerolle JP, Barrou B, Grimbert P, Chatelet V, Mousson C, Janbon B, Pernin V, Frimat L, Ouali N, Glotz D, Thierry A, Mariat C, Buchler M, Gaulard P, Leblond V, Morelon E, Dubois V, Salles G, Caillard S, Thaunat O
  Transplantation · PubMed

2020

• Commercialanti-CD19 CART cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
  Sesques P, Ferrant E, Safar V, Wallet F, Tordo J, Dhomps A, Karlin L, Brisou G, Vercasson M, Hospital-Gustem C, Schwiertz V, Ranchon F, Rioufol C, Choquet M, Sujobert P, Ghergus D, Bouafia F, Golfier C, Lequeu H, Lazareth A, Novelli S, Devic P, Traverse-Glehen A, Viel S, Venet F, Mialou V, Hequet O, Chauchet A, Arkam Y, Nicolas-Virelizier E, Peyrade F, Cavalieri D, Ader F, Ghesquieres H, Salles G, Bachy E
  American Journal of Hematology · PubMed

• Lymphoid involvement of cerebrospinal fluid in Lyme disease
  Lefeuve F, Baseggio L
  Annales De Biologie Clinique · PubMed

• FRIPON: a worldwide network to track incoming meteoroids
  Colas F, Zanda B, Bouley S, Jeanne S, Malgoyre A, Birlan M, Blanpain C, Gattacceca J, Jorda L, Lecubin J, Marmo C, Rault JL, Vaubaillon J, Vernazza P, Yohia C, Gardiol D, Nedelcu A, Poppe B, Rowe J, Forcier M, Koschny D, Trigo-Rodriguez JM, Lamy H, Behrend R, Ferriere L, Barghini D, Buzzoni A, Carbognani A, Di Carlo M, Di Martino M, Knapic C, Londero E, Pratesi G, Rasetti S, Riva W, Stirpe GM, Valsecchi GB, Volpicelli CA, Zorba S, Coward D, Drolshagen E, Drolshagen G, Hernandez O, Jehin E, Jobin M, King A, Nitschelm C, Ott T, Sanchez-Lavega A, Toni A, Abraham P, Affaticati F, Albani M, Andreis A, Andrieu T, Anghel S, Antaluca E, Antier K, Appere T, Armand A, Ascione G, Audureau Y, Auxepaules G, Avoscan T, Baba Aissa D, Bacci P, Badescu O, Baldini R, Baldo R, Balestrero A, Baratoux D, Barbotin E, Bardy M, Basso S, Bautista O, Bayle LD, Beck P, Bellitto R, Belluso R, Benna C, Benammi M, Beneteau E, Benkhaldoun Z, Bergamini P, Bernardi F, Bertaina ME, Bessin P, Betti L, Bettonvil F, Bihel D, Birnbaum C, Blagoi O, Blouri E, Boaca I, Boata R, Bobiet B, Bonino R, Boros K, Bouchet E, Borgeot V, Bouchez E, Boust D, Boudon V, Bouman T, Bourget P, Brandenburg S, Bramond P, Braun E, Bussi A, Cacault P, Caillier B, Calegaro A, Camargo J, Caminade S, Campana APC, Campbell-Burns P, Canal-Domingo R, Carell O, Carreau S, Cascone E, Cattaneo C, Cauhape P, Cavier P, Celestin S, Cellino A, Champenois M, Chennaoui Aoudjehane H, Chevrier S, Cholvy P, Chomier L, Christou A, Cricchio D, Coadou P, Cocaign JY, Cochard F, Cointin S, Colombi E, Colque Saavedra JP, Corp L, Costa M, Costard F, Cottier M, Cournoyer P, Coustal E, Cremonese G, Cristea O, Cuzon JC, D’Agostino G, Daiffallah K, Danescu C, Dardon A, Dasse T, Davadan C, Debs V, Defaix JP, Deleflie F, D’Elia M, De Luca P, De Maria P, Deverchere P, Devillepoix H, Dias A, Di Dato A, Di Luca R, Dominici FM, Drouard A, Dumont JL, Dupouy P, Duvignac L, Egal A, Erasmus N, Esseiva N, Ebel A, Eisengarten B, Federici F, Feral S, Ferrant G, Ferreol E, Finitzer P, Foucault A, Francois P, Frincu M, Froger JL, Gaborit F, Gagliarducci V, Galard J, Gardavot A, Garmier M, Garnung M, Gautier B, Gendre B, Gerard D, Gerardi A, Godet JP, Grandchamps A, Grouiez B, Groult S, Guidetti D, Giuli G, Hello Y, Henry X, Herbreteau G, Herpin M, Hewins P, Hillairet JJ, Horak J, Hueso R, Huet E, Huet S, Hyaume F, Interrante G, Isselin Y, Jeangeorges Y, Janeux P, Jeanneret P, Jobse K, Jouin S, Jouvard JM, Joy K, Julien JF, Kacerek R, Kaire M, Kempf M, Koschny D, Krier C, Kwon MK, Lacassagne L, Lachat D, Lagain A, Laisne E, Lanchares V, Laskar J, Lazzarin M, Leblanc M, Lebreton JP, Lecomte J, Le Du P, Lelong F, Lera S, Leoni JF, Le-Pichon A, Le-Poupon P, Leroy A, Leto G, Levansuu A, Lewin E, Lienard A, Licchelli D, Locatelli H, Loehle S, Loizeau D, Luciani L, Maignan M, Manca F, Mancuso S, Mandon E, Mangold N, Mannucci F, Maquet L, Marant D, Marchal Y, Marin JL, Martin-Brisset JC, Martin D, Mathieu D, Maury A, Mespoulet N, Meyer F, Meyer JY, Meza E, Moggi Cecchi V, Moiroud JJ, Millan M, Montesarchio M, Misiano A, Molinari E, Molau S, Monari J, Monflier B, Monkos A, Montemaggi M, Monti G, Moreau R, Morin J, Mourgues R, Mousis O, Nablanc C, Nastasi A, Niacsu L, Notez P, Ory M, Pace E, Paganelli MA, Pagola A, Pajuelo M, Palacian JF, Pallier G, Paraschiv P, Pardini R, Pavone M, Pavy G, Payen G, Pegoraro A, Pena-Asensio E, Perez L, Perez-Hoyos S, Perlerin V, Peyrot A, Peth F, Pic V, Pietronave S, Pilger C, Piquel M, Pisanu T, Poppe M, Portois L, Prezeau JF, Pugno N, Quantin C, Quitte G, Rambaux N, Ravier E, Repetti U, Ribas S, Richard C, Richard D, Rigoni M, Rivet JP, Rizzi N, Rochain S, Rojas JF, Romeo M, Rotaru M, Rotger M, Rougier P, Rousselot P, Rousset J, Rousseu D, Rubiera O, Rudawska R, Rudelle J, Ruguet JP, Russo P, Sales S, Sauzereau O, Salvati F, Schieffer M, Schreiner D, Scribano Y, Selvestrel D, Serra R, Shengold L, Shuttleworth A, Smareglia R, Sohy S, Soldi M, Stanga R, Steinhausser A, Strafella F, Sylla Mbaye S, Smedley ARD, Tagger M, Tanga P, Taricco C, Teng JP, Tercu JO, Thizy O, Thomas JP, Tombelli M, Trangosi R, Tregon B, Trivero P, Tukkers A, Turcu V, Umbriaco G, Unda-Sanzana E, Vairetti R, Valenzuela M, Valente G, Varennes G, Vauclair S, Vergne J, Verlinden M, Vidal-Alaiz M, Vieira-Martins R, Viel A, Vintdevara DC, Vinogradoff V, Volpini P, Wendling M, Wilhelm P, Wohlgemuth K, Yanguas P, Zagarella R, Zollo A
  Astronomy & Astrophysics · PubMed

• International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI
  Ruppert AS, Dixon JG, Salles G, Wall A, Cunningham D, Poeschel V, Haioun C, Tilly H, Ghesquieres H, Ziepert M, Flament J, Flowers C, Shi Q, Schmitz N
  Blood · PubMed

• Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL
  Laurent C, Nicolae A, Laurent C, Le Bras F, Haioun C, Fataccioli V, Amara N, Adelaide J, Guille A, Schiano JM, Tesson B, Traverse-Glehen A, Chenard MP, Mescam L, Moreau A, Chassagne-Clement C, Somja J, Escudie F, Andre M, Martin N, Lacroix L, Lemonnier F, Hamy AS, Reyal F, Bannier M, Oberic L, Prade N, Frenois FX, Beldi-Ferchiou A, Delfau-Larue MH, Bouabdallah R, Birnbaum D, Brousset P, Xerri L, Gaulard P
  Blood · PubMed

• Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors
  Frank AM, Braun AH, Scheib L, Agarwal S, Schneider IC, Fusil F, Perian S, Sahin U, Thalheimer FB, Verhoeyen E, Buchholz CJ
  Blood Advances · PubMed

• Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
  Lewis NE, Petrova-Drus K, Huet S, Epstein-Peterson ZD, Gao Q, Sigler AE, Baik J, Ozkaya N, Moskowitz AJ, Kumar A, Horwitz SM, Zhang YM, Arcila ME, Levine RL, Roshal M, Dogan A, Xiao WB
  Blood Advances · PubMed

• Gene expression profiling of gray zone lymphoma
  Sarkozy C, Chong L, Takata K, Chavez EA, Miyata-Takata T, Duns G, Telenius A, Boyle M, Slack GW, Laurent C, Farinha P, Molina TJ, Copie-Bergman C, Damotte D, Salles GA, Mottok A, Savage KJ, Scott DW, Traverse-Glehen A, Steidl C
  Blood Advances · PubMed

• Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
  Yabe M, Gao Q, Ozkaya N, Huet S, Lewis N, Pichardo JD, Moskowitz AJ, Horwitz SM, Dogan A, Roshal M
  Blood Cancer Journal · PubMed

• Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)
  Wallet F, Bachy E, Vassal O, Friggeri A, Bohe J, Garnier L, Salles G, Allaouchiche B
  Bone Marrow Transplantation · PubMed

• Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases
  Aussedat G, Traverse-Glehen A, Stamatoullas A, Molina T, Safar V, Laurent C, Michot JM, Hirsch P, Nicolas-Virelizier E, Lamure S, Regny C, Picquenot JM, Ledoux-Pilon A, Tas P, Chassagne-Clement C, Manson G, Lemal R, Fontaine J, Le Cann M, Salles G, Ghesquieres H, Copie-Bergman C, Sarkozy C
  British Journal of Haematology · PubMed

• Recommendations from the French CML Study Group (Fi-LMC) for BCR-ABL1 kinase domain mutation analysis in chronic myeloid leukemia
  Cayuela JM, Chomel JC, Coiteux V, Dulucq S, Escoffre-Barbe M, Etancelin P, Etienne G, Hayette S, Millot F, Nibourel O, Nicolini FE, Rea D
  Bulletin Du Cancer · PubMed

• COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
  Baruchel A, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, Halfon-Domenech C, Leblanc T, Leverger G, Michel G, Petit A, Ray-Lunven AF, Rohrlich PS, Schneider P, Sirvent N, Strullu M
  Bulletin Du Cancer · PubMed

• Acute Promyelocytic Leukemia
  Thomas X, Heiblig M
  Cancers · PubMed

• Towards Physiologically and Tightly Regulated Vectored Antibody Therapies
  Page A, Fusil F, Cosset FL
  Cancers · PubMed

• Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse
  Pangault C, Ame-Thomas P, Rossille D, Dulong J, Caron G, Nonn C, Chatonnet F, Desmots F, Launay V, Lamy T, Fest T, Tarte K
  Cancers · PubMed

• Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant
  Libre C, Moro-Sibilot L, Giraud S, Martin L, Verhoeyen E, Costa C, Chebel A, Bissay N, Salles G, Genestier L, Sujobert P
  Cancers · PubMed

• Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers
  Alcazer V, Bonaventura P, Depil S
  Cancers · PubMed

• Vitamin D Receptor Controls Cell Sternness in Acute Myeloid Leukemia and in Normal Bone Marrow
  Paubelle E, Zylbersztejn F, Maciel TT, Carvalho C, Mupo A, Cheok M, Lieben L, Sujobert P, Decroocq J, Yokoyama A, Asnafi V, Macintyre E, Tamburini J, Bardet V, Castaigne S, Preudhomme C, Dombret H, Carmeliet G, Bouscary D, Ginzburg YZ, de The H, Benhamou M, Monteiro RC, Vassiliou GS, Hermine O, Moura IC
  Cell Reports · PubMed

• Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease
  Hammoudi N, Cazals-Hatem D, Auzolle C, Gardair C, Ngollo M, Bottois H, Nancey S, Pariente B, Buisson A, Treton X, Fumery M, Bezault M, Seksik P, Le Bourhis L, Flejou JF, Allez M, Cattan P, Chirica M, Munoz-Bongrand N, Corte H, Beaupel N, Catry J, Gornet JM, Baudry C, Lourenco N, Maillet M, Tran-Minh ML, Chardiny V, Grand C, Gergaud B, Bonnet J, Chedouba L, Nisard A, Beaugerie L, Sokol H, Bourrier A, Nion-Larmurier I, Kirchgesner J, Quevrain E, Brot L, Chafai N, Lefevre JH, Tiret E, Svrcek M, Guedj N, Panis Y, Magiorri L, Ferron M, Bouhnik Y, Corcos O, Stefanescu C, Marteau P, Dray X, Chaput U, Kaci R, Dubois A, Bommelaer G, Goutte M, Barnich N, Coban D, Godfraind C, Zakeyh JJ, Desreumaux P, Nachury M, Sommeville C, Renaud F, Dupas JL, Loreau J, Brazier F, Chatelain D, Attencourt C, Sabbagh C, Leconte M, Boschetti G, Flourie B, Francois Y, Cotte E, Charlois AL, Falgon P, Hadjisavvas H, Moussata D, Chauvenet M, Boyer S, Traverse-Glehen A, Hebuterne X, Filippi J, Hofmann P, Rahili A, Patouraux S, Jouven X
  Clinical Gastroenterology and Hepatology · PubMed

• Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients
  Gobbini E, Toffart AC, Perol M, Assie JB, Duruisseaux M, Coupez D, Dubos C, Westeel V, Delaunay M, Guisier F, Veillon R, Gounant V, Leprieur EG, Vanel FR, Chaabane N, Dansin E, Babey H, Decroisette C, Barlesi F, Daniel C, Fournel P, Mezquita L, Oulkhouir Y, Canellas A, Duchemann B, Molinier O, Alcazer V, Moro-Sibilot D, Levra MG
  Clinical Lung Cancer · PubMed

• Phoenician and Punic
  Chatonnet F, Hawley R
  Companion to Ancient near Eastern Languages · PubMed

• Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma
  Bourbon E, Salles G
  Expert Opinion on Investigational Drugs · PubMed

• An evaluation of glasdegib for the treatment of acute myelogenous leukemia
  Thomas X, Heiblig M
  Expert Opinion on Pharmacotherapy · PubMed

• Emerging pharmacotherapies for elderly acute myeloid leukemia patients
  Thomas X, Elhamri M, Heiblig M
  Expert Review of Hematology · PubMed

• Enasidenib for the treatment of relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutation
  Heiblig M, Hachem-Khalife S, Willekens C, Micol JB, Paci A, Penard-Lacronique V, de Bottona S
  Expert Review of Precision Medicine and Drug Development · PubMed

• Genetically Determined Height and Risk of Non-hodgkin Lymphoma
  Moore A, Kane E, Wang ZM, Panagiotou OA, Teras LR, Monnereau A, Doo NW, Machiela MJ, Skibola CF, Slager SL, Salles G, Camp NJ, Bracci PM, Nieters A, Vermeulen RCH, Vijai J, Smedby KE, Zhang YW, Vajdic CM, Cozen W, Spinelli JJ, Hjalgrim H, Giles GG, Link BK, Clavel J, Arslan AA, Purdue MP, Tinker LF, Albanes D, Ferri GM, Habermann TM, Adami HO, Becker N, Benavente Y, Bisanzi S, Boffetta P, Brennan P, Brooks-Wilson AR, Canzian F, Conde L, Cox DG, Curtin K, Foretova L, Gapstur SM, Ghesquieres H, Glenn M, Glimelius B, Jackson RD, Lan Q, Liebow M, Maynadie M, McKay J, Melbye M, Miligi L, Milne RL, Molina TJ, Morton LM, North KE, Offit K, Padoan M, Patel AV, Piro S, Ravichandran V, Riboli E, de Sanjose S, Severson RK, Southey MC, Staines A, Stewart C, Travis RC, Weiderpass E, Weinstein S, Zheng TZ, Chanock SJ, Chatterjee N, Rothman N, Birmann BM, Cerhan JR, Berndt SI
  Frontiers in Oncology · PubMed

• The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation
  Chatonnet F, Pignarre A, Serandour AA, Caron G, Avner S, Robert N, Kassambara A, Laurent A, Bizot M, Agirre X, Prosper F, Martin-Subero JI, Moreaux J, Fest T, Salbert G
  Haematologica · PubMed

• Patrolling Monocytes Watch Over Relapse
  Tesio M
  Hemasphere · PubMed

• Relapse-Fated Subclones: Finding the Needle in the Haystack
  Tesio M
  Hemasphere · PubMed

• Starving Drug Resistance
  Tesio M
  Hemasphere · PubMed

• Controversies in the Treatment of Peripheral T-cell Lymphoma
  Bachy E, Broccoli A, Dearden C, de Leval L, Gaulard P, Koch R, Morschhauser F, Trumper L, Zinzani PL
  Hemasphere · PubMed

• Drug cost savings in phaseIIIhematological oncology clinical trials in a university hospital
  Herledan C, Ranchon F, Schwiertz V, Baudouin A, Karlin L, Ghesquieres H, Salles G, Rioufol C
  Hematological Oncology · PubMed

• Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era
  Sesques P, Bourcier J, Golfier C, Lebras L, Nicolas-Virelizier E, Hacini M, Perrin MC, Voillat L, Bachy E, Traverse-Glehen A, Moreau A, Martin L, Ramla S, Casasnovas O, Le Gouill S, Salles G, Ghesquieres H
  Hematological Oncology · PubMed

• Poorly differentiated neuroendocrine carcinoma of the head and neck: human papillomavirus tumour status/p16 status and impact on overall survival
  Benzerdjeb N, Traverse-Glehen A, Philouze P, Bishop J, Devouassoux-Shisheboran M
  Histopathology · PubMed

• Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis
  Benzerdjeb N, Durieux E, Tantot J, Isaac S, Fontaine J, Harou O, Glehen O, Kepenekian V, Alyami M, Villeneuve L, Laplace N, Traverse-Glehen A, Shisheboran-Devouassoux M, Bakrin N
  Histopathology · PubMed

• Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways
  Kleinstern G, Yan HH, Hildebrandt MAT, Vijai J, Berndt SI, Ghesquieres H, McKay J, Wang SS, Nieters A, Ye Y, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, Teras LR, Purdue MP, Vajdic CM, Vermeulen RCH, Giles GG, Cocco PL, Birmann BM, Kraft P, Albanes D, Zeleniuch-Jacquotte A, Crouch S, Zhang YW, Sarangi V, Asmann Y, Offit K, Salles G, Wu XF, Smedby KE, Skibola CF, Slager SL, Rothman N, Chanock SJ, Cerhan JR
  Human Molecular Genetics · PubMed

• Potential of Circulating Tumor DNA for the Management of Patients With Lymphoma
  Huet S, Salles G
  Jco Oncology Practice · PubMed

• The novel torn to pieces: adaptation and scenic rewriting
  Bourbon E
  Jeu-Revue De Theatre · PubMed

• Early Off-Study Experience of Chimeric Antigen Receptor T Cells in Aggressive Lymphoma: Closer to a Real-World Setting
  Ghesquieres H, Salles G
  Journal of Clinical Oncology · PubMed

• Blueprint of human thymopoiesis reveals molecular mechanisms of stage-specific TCR enhancer activation
  Cieslak A, Charbonnier G, Tesio M, Mathieu EL, Belhocine M, Touzart A, Smith C, Hypolite G, Andrieu GP, Martens JHA, Janssen-Megens E, Gut M, Gut I, Boissel N, Petit A, Puthier D, Macintyre E, Stunnenberg HG, Spicuglia S, Asnafi V
  Journal of Experimental Medicine · PubMed

• Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
  Chen AP, Mokrane FZ, Schwartz LH, Morschhauser F, Stamatoullas A, de Colella JMS, Vercellino L, Casasnovas O, Chauchet A, Delmer A, Nicolas-Virelizier E, Ghesquieres H, Moles-Moreau MP, Schmitt A, Dulery R, Bouabdallah K, Borel C, Touati M, Deau-Fischer B, Peyrade F, Seban RD, Manson G, Armand P, Houot R, Dercle L
  Journal of Nuclear Medicine · PubMed

• Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia
  Huet S, Bouvard A, Ferrant E, Mosnier I, Chabane K, Salles G, Michallet AS, Hayette S, Sujobert P
  Leukemia · PubMed

• Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT
  Martinez C, Boumendil A, Romejko-Jarosinska J, Anagnostopoulos A, Faber E, Poire X, Yakoub-Agha I, Akhtar S, Gurman G, Pavone V, Halaburda K, Sousa AB, Ghesquieres H, Finel H, Khvedelidze I, Montoto S, Sureda A
  Leukemia & Lymphoma · PubMed

• Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a ‘Real-Life’ Study
  Laurino M, Loron S, Larcher MV, Fossard G, Elhamri M, Deloire A, Balsat M, Barraco F, Labussiere H, Ducastelle S, Renault M, Wattel E, Heiblig M, Salles G, Thomas X
  Mediterranean Journal of Hematology and Infectious Diseases · PubMed

• Some Remarks About a Metal Plaque Inscribed in Syriac
  Chatonnet F, Desreumaux A
  Museon · PubMed

• Management and outcome of primary CNS lymphoma in the modern era An LOC network study
  Houillier C, Soussain C, Ghesquieres H, Soubeyran P, Chinot O, Taillandier L, Lamy T, Choquet S, Ahle G, Damaj G, Agape P, Molucon-Chabrot C, Amiel A, Delwail V, Fabbro M, Jardin F, Chauchet A, Moles-Moreau MP, Morschhauser F, Casasnovas O, Gressin R, Fornecker LM, Abraham J, Marolleau JP, Tempescul A, Campello C, Colin P, Tamburini JM, Laribi K, Serrier C, Haioun C, Chebrek S, Schmitt A, Blonski M, Houot R, Boyle E, Bay JO, Oberic L, Tabouret E, Waultier A, Martin-Duverneuil N, Touitou V, Cassoux N, Kas A, Mokhtari K, Charlotte F, Alentorn A, Feuvret L, Le Garff-Tavernier M, Costopoulos M, Mathon B, Peyre M, Delgadillo D, Douzane H, Genet D, Aidaoui B, Hoang-Xuan K, Gyan E
  Neurology · PubMed

• Development of Vitreoretinal Lymphoma in a Patient with Sarcoid Uveitis
  Wartique L, Jamilloux Y, De Bernecourt AD, Kodjikian L, Ghesquieres H, Ide C, Seve P
  Ocular Immunology and Inflammation · PubMed

• Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
  Perichou J, Ranchon F, Herledan C, Huot L, Larbre V, Carpentier I, Lazareth A, Karlin L, Beny K, Vantard N, Schwiertz V, Caffin AG, Baudouin A, Sesques P, Brisou G, Ghesquieres H, Salles G, Rioufol C
  Plos One · PubMed

• Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production
  Chabrolles H, Auclair H, Vegna S, Lahlali T, Pons C, Michelet M, Coute Y, Belmudes L, Chadeuf G, Kim Y, Di Bernardo A, Jalaguier P, Cosset FL, Fusil F, Rivoire M, Arnold LD, Lopatin U, Combet C, Zoulim F, Grierson D, Chabot B, Lucifora J, Durantel D, Salvetti A
  Plos Pathogens · PubMed

• Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed of Refractory Hodgkin Lymphoma
  Mokrane FZ, Chen AP, Schwartz LH, Morschhauser F, Stamatoullas A, de Colella JMS, Vercellino L, Casasnovas O, Chauchet A, Delmer A, Nicolas-Virelizier E, Ghesquieres H, Moles-Moreau MP, Schmitt A, Dulery R, Bouabdallah K, Borel C, Touati M, Deau-Fischer B, Peyrade F, Seban RD, Manson G, Houot R, Dercle L
  Radiology · PubMed

• Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
  Belin C, Devic P, Ayrignac X, Dos Santos A, Paix A, Sirven-Villaros L, Simard C, Lamure S, Gastinne T, Ursu R, Berger C, Platon L, Tessoulin B, Azoulay E, Wallet F, Thieblemont C, Bachy E, Cartron G, Laplaud DA, Carpentier AF
  Scientific Reports · PubMed

• Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis
  King RL, Goodlad JR, Calaminici M, Dotlic S, Montes-Moreno S, Oschlies I, Ponzoni M, Traverse-Glehen A, Ott G, Ferry JA
  Virchows Archiv · PubMed

• Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas
  Montes-Moreno S, King RL, Oschlies I, Ponzoni M, Goodlad JR, Dotlic S, Traverse-Glehen A, Ott G, Ferry JA, Calaminici M
  Virchows Archiv · PubMed

• The broad and challenging landscape of extranodal lymphoproliferations
  Dotlic S, Ponzoni M, King RL, Oschlies I, Ferry J, Calaminici M, Montes-Moreno S, Goodlad JR, Ott G, Traverse-Glehen A
  Virchows Archiv · PubMed

• The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome
  Oschlies I, King RL, Dotlic S, Montes-Moreno S, Ponzoni M, Traverse-Glehen A, Calaminici M, Ferry JA, Ott G, Goodlad JR
  Virchows Archiv · PubMed

• Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
  Page A, Fusil F, Cosset FL
  Viruses-Basel · PubMed

2019

• Early-onset severe infections in allogeneic hematopoietic stem cell transplantation recipients with graft failure
  Alcazer V, Conrad A, Valour F, Bachy E, Salles G, Huynh A, de Latour RP, Labussiere-Wallet H, Ader F
  American Journal of Hematology · PubMed

• Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma A Histopathologic Series From the LYSA
  Sarkozy C, Copie-Bergman C, Damotte D, Ben-Neriah S, Burroni B, Cornillon J, Lemal R, Golfier C, Fabiani B, Chassagne-Clement C, Parrens M, Herbaux C, Xerri L, Bossard C, Laurent C, Cheminant M, Cartron G, Cabecadas J, Molina T, Salles G, Steidl C, Ghesquieres H, Mottok A, Traverse-Glehen A
  American Journal of Surgical Pathology · PubMed

• Accreditation strategy for rare somatic molecular abnormalities detected or quantified by polymerase chain reaction: GBMHM recommendations
  Sujobert P, Dulucq S, Alary AS, Etancelin P, Bouvier A, Boureau L, Chauveau A, Kosmider O, Flandrin P
  Annales De Biologie Clinique · PubMed

• Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
  Salles G, Bachy E, Smolej L, Simkovic M, Baseggio L, Panovska A, Besson H, Healy N, Garside J, Iraqi W, Diels J, Pick-Lauer C, Spacek M, Urbanova R, Lysak D, Hermans R, Lundbom J, Callet-Bauchu E, Doubek M
  Annals of Hematology · PubMed

• Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
  Dulucq S, Etienne G, Morisset S, Klein E, Chollet C, Robbesyn F, Turcq B, Tigaud I, Hayette S, Nicolini FE, Mahon FX
  Annals of Hematology · PubMed

• Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
  Ghesquieres H, Chevrier M, Laadhari M, Chinot O, Choquet S, Molucon-Chabrot C, Beauchesne P, Gressin R, Morschhauser F, Schmitt A, Gyan E, Hoang-Xuan K, Nicolas-Virelizier E, Cassoux N, Touitou V, Le Garff-Tavernier M, Savignoni A, Turbiez I, Soumelis V, Houillier C, Soussain C
  Annals of Oncology · PubMed

• One translocation for 2 lymphoid neoplasms
  Aussedat G, Baseggio L
  Blood · PubMed

• Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
  Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, Shustov A, Tournilhac O, Bachy E, Zaja F, Porkka K, Hoermann G, Simonitsch-Klupp I, Haferlach C, Kubicek S, Mayerhoefer ME, Hopfinger G, Jaeger U, Dearden C
  Blood · PubMed

• Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
  Chapiro E, Pramil E, Diop M, Roos-Weil D, Dillard C, Gabillaud C, Maloum K, Settegrana C, Baseggio L, Lesesve JF, Yon M, Jondreville L, Lesty C, Davi F, Le Garff-Tavernier M, Droin N, Dessen P, Algrin C, Leblond V, Gabarre J, Bouzy S, Eclache V, Gaillard B, Callet-Bauchu E, Muller M, Lefebvre C, Nadal N, Ittel A, Struski S, Collonge-Rame MA, Quilichini B, Fert-Ferrer S, Auger N, Radford-Weiss I, Wagner L, Scheinost S, Zenz T, Susin SA, Bernard OA, Nguyen-Khac F
  Blood · PubMed

• Cannibalistic acute myeloid leukemia with ZMYND11-MBTD1 fusion
  Plesa A, Sujobert P
  Blood · PubMed

• How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
  Garnache-Ottou F, Vidal C, Biichl S, Renosi F, Poret E, Pagadoy M, Desmarets M, Roggy A, Seilles E, Soret L, Schillinger F, Puyraimond S, Petrella T, Preudhomme C, Roumier C, MacIntyre EA, Harrivel V, Desbrosses Y, Gruson B, Genevieve F, Thepot S, Drebit Y, Leguay T, Gros FX, Lechevalier N, Saussoy P, Salaun V, Cornet E, Benseddik Z, Veyrat-Masson R, Wagner-Ballon O, Salanoubat C, Maynadi M, Guy J, Caillot D, Jacob MC, Cahn JY, Gressin R, Rose J, Quesnel B, Guerin E, Trimoreau F, Feuillard J, Gourin MP, Plesa A, Baseggio L, Arnoux I, Vey N, Blaise D, Lacroix R, Arnoulet C, Benet B, Dorvaux V, Bret C, Drenou B, Debliquis A, Latger-Cannard V, Bonmati C, Bene MC, Peterlin P, Ticchioni M, Rohrlich PS, Arnaud A, Wickenhauser S, Bardet V, Brechignac S, Papoular B, Raggueneau V, Vargaftig J, Letestu R, Lusina D, Braun T, Foissaud V, Tamburini J, Bennani H, Freynet N, Cordonnier C, Le Garff-Tavernier M, Jacques N, Maloum K, Roos-Weil D, Bouscary D, Asnafi V, Lhermitte L, Suarez F, Lengline E, Feger F, Battipaglia G, Mohty M, Bouyer S, Ghoual O, Dindinaud E, Basle C, Puyade M, Lafon C, Fest T, Roussel M, Cahu X, Bera E, Daliphard S, Jardin F, Campos L, Solly F, Guyotat D, Galoisy AC, Eischen A, Mayeur-Rousse C, Guffroy B, Recher C, Loosveld M, Garnier A, Barlogis V, Rosenthal MA, Brun S, Contentin N, Maury S, Callanan M, Lefebvre C, Maillard N, Okamba P, Ferrand C, Adotevi O, Saas P, Angelot-Delettre F, Binda D, Deconinck E
  Blood Advances · PubMed

• Diversity and evolution of the transposable element repertoire in arthropods with particular reference to insects
  Petersen M, Armisen D, Gibbs RA, Hering L, Khila A, Mayer G, Richards S, Niehuis O, Misof B
  Bmc Evolutionary Biology · PubMed

• VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients
  Conrad A, Boccard M, Valour F, Alcazer V, Sanchez ATT, Chidiac C, Laurent F, Vanhems P, Salles G, Brengel-Pesce K, Meunier B, Trouillet-Assant S, Ader F
  Bmj Open · PubMed

• Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors
  Alcazer V, de Latour RP, Ader F, Labussiere-Wallet H
  Bulletin Du Cancer · PubMed

• Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party
  Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Blaise D, Peggs KS, Afanasyev B, Diez-Martin JL, Corradini P, Michonneau D, Robinson S, Gutierrez Garcia G, Bonifazi F, Yakoub-Agha I, Gulbas Z, Bloor A, Delage J, Esquirol A, Malladi R, Scheid C, El-Cheikh J, Ghesquieres H, Montoto S, Dreger P, Sureda A
  Cancer · PubMed

• GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-?B-Dependent Mechanism
  Mondragon L, Mhaidly R, De Donatis GM, Tosolini M, Dao P, Martin AR, Pons C, Chiche J, Jacquin M, Imbert V, Proics E, Boyer L, Doye A, Luciano F, Neels JG, Coutant F, Fabien N, Sormani L, Rubio-Patino C, Bossowski JP, Muller F, Marchetti S, Villa E, Peyron JF, Gaulard P, Lemonnier F, Asnafi V, Genestier L, Benhida R, Foumie JJ, Passeron T, Ricci JE, Verhoeyen E
  Cancer Cell · PubMed

• Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors
  Etienne G, Dulucq S, Huguet F, Schmitt A, Lascaux A, Hayette S, Fort MP, Sujobert P, Bijou F, Morisset S, Tavitian S, Bidet A, Turcq B, Robbesyn F, Chollet C, Belloc F, Durrieu F, Mahon FX, Nicolini FE
  Cancer Medicine · PubMed

• Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort
  Degaud M, Baseggio L, Grange B, Manzoni D, Huet S, Callet-Bauchu E, Traverse-Glehen A, Davi F, Ghesquieres H, Salles G, Sujobert P
  Cancers · PubMed

• Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience
  Heiblig M, Labussiere-Wallet H, Nicolin FE, Michallet M, Hayette S, Sujobert P, Plesa A, Balsat M, Paubelle E, Barraco F, Tigaud I, Ducastelle S, Wattel E, Salles G, Thomas X
  Cancers · PubMed

• Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience
  Solly F, Angelot-Delettre F, Ticchioni M, Genevieve F, Rambaud H, Baseggio L, Plesa A, Debliquis A, Garnache-Ottou F, Roggy A, Campos L, Aanei C, Rosenthal-Allieri A, Georget MT, Lachot S, Jacob MC, Robillard N, Wuilleme S, Andre-Kerneis E, Cornet E, Salaun V, Bennami H, Lhoumeau AC, Arnoulet C, Jacqmin H, Neyman N, Latger-Cannard V, Massin F, Lainey E, Le Garff-Tavernier M, Costopoulos M, Roussel M, Mayeur-Rousse C, Eischen A, Raggeneau V, Derrieux C, Maurer M, Asnafi V, Trinquand A, Brouzes C, Lhermitte L
  Cytometry Part A · PubMed

• Neoepitopes-based vaccines: challenges and perspectives
  Alcazer V, Bonaventura P, Tonon L, Wittmann S, Caux C, Depil S
  European Journal of Cancer · PubMed

• Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
  Manson G, Mear JB, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Garnier G, Regny C, Bouabdallah K, Moles-Moreau MP, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Chauchet A, Damotte D, Dercle L, Brice P, Houot R
  European Journal of Cancer · PubMed

• Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
  Soussain C, Choquet S, Blonski M, Leclercq D, Houillier C, Rezai K, Bijou F, Houot R, Boyle E, Gressin R, Nicolas-Virelizier E, Barrie M, Molucon-Chabrot C, Lelez ML, Clavert A, Coisy S, Leruez S, Touitou V, Cassoux N, Daniau M, de la Bretonniere ME, El Yamani A, Ghesquieres H, Hoang-Xuan K
  European Journal of Cancer · PubMed

• Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies
  Dercle L, Mokrane FZ, de Colella JMS, Stamatoullas A, Morschhauser F, Brice P, Ghesquieres H, Casasnovas O, Chen AP, Manson G, Houot R
  European Journal of Nuclear Medicine and Molecular Imaging · PubMed

• Farnesoid X receptor- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo
  Mouzannar K, Fusil F, Lacombe B, Ollivier A, Menard C, Lotteau V, Cosset FL, Ramiere C, Andre P
  Faseb Journal · PubMed

• Escalation and Morphological Constraints of Antagonistic Armaments in Water Striders
  Crumiere AJJ, Armisen D, Vargas-Lowman A, Kubarakos M, Moreira FFF, Khila A
  Frontiers in Ecology and Evolution · PubMed

• Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression
  Dahdal S, Saison C, Valette M, Bachy E, Pallet N, Lina B, Koenig A, Monneret G, Defrance T, Morelon E, Thaunat O
  Frontiers in Immunology · PubMed

• Cold Tumors: A Therapeutic Challenge for Immunotherapy
  Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S
  Frontiers in Immunology · PubMed

• Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes
  Din L, Sheikh M, Kosaraju N, Smedby KE, Bernatsky S, Berndt SI, Skibola CF, Nieters A, Wang S, McKay JD, Cocco P, Maynadie M, Foretova L, Staines A, Mack TM, de Sanjose S, Vyse TJ, Padyukov L, Monnereau A, Arslan AA, Moore A, Brooks-Wilson AR, Novak AJ, Glimelius B, Birmann BM, Link BK, Stewart C, Vajdic CM, Haioun C, Magnani C, Conti DV, Cox DG, Casabonne D, Albanes D, Kane E, Roman E, Muzi G, Salles G, Giles GG, Adami HO, Ghesquieres H, De Vivo I, Clavel J, Cerhan JR, Spinelli JJ, Hofmann J, Vijai J, Curtin K, Costenbader KH, Onel K, Offit K, Teras LR, Morton L, Conde L, Miligi L, Melbye M, Ennas MG, Liebow M, Purdue MP, Glenn M, Southey MC, Din M, Rothman N, Camp NJ, Doo NW, Becker N, Pradhan N, Bracci PM, Boffetta P, Vineis P, Brennan P, Kraft P, Lan Q, Severson RK, Vermeulen RCH, Milne RL, Kaaks R, Travis RC, Weinstein SJ, Chanock SJ, Ansell SM, Slager SL, Zheng TZ, Zhang YW, Benavente Y, Taub Z, Madireddy L, Gourraud PA, Oksenberg JR, Cozen W, Hjalgrim H, Khankhanian P
  Genetic Epidemiology · PubMed

• Molecular evolutionary trends and feeding ecology diversification in the Hemiptera, anchored by the milkweed bug genome
  Panfilio KA, Jentzsch IMV, Benoit JB, Erezyilmaz D, Suzuki Y, Colella S, Robertson HM, Poelchau MF, Waterhouse RM, Ioannidis P, Weirauch MT, Hughes DST, Murali SC, Werren JH, Jacobs CGC, Duncan EJ, Armisen D, Vreede BMI, Baa-Puyoulet P, Berger CS, Chang C, Chao H, Chen MJM, Chen YT, Childers CP, Chipman AD, Cridge AG, Crumiere AJJ, Dearden PK, Didion EM, Dinh H, Doddapaneni HV, Dolan A, Dugan S, Extavour CG, Febvay G, Friedrich M, Ginzburg N, Han Y, Heger P, Holmes CJ, Horn T, Hsiao Y, Jennings EC, Johnston JS, Jones TE, Jones JW, Khila A, Koelzer S, Kovacova V, Leask M, Lee SL, Lee CY, Lovegrove MR, Lu HL, Lu Y, Moore PJ, Munoz-Torres MC, Muzny DM, Palli SR, Parisot N, Pick L, Porter ML, Qu JX, Refki PN, Richter R, Rivera-Pomar R, Rosendale AJ, Roth S, Sachs L, Santos ME, Seibert J, Sghaier E, Shukla JN, Stancliffe RJ, Tidswell O, Traverso L, van der Zee M, Viala S, Worley KC, Zdobnov EM, Gibbs RA, Richards S
  Genome Biology · PubMed

• Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses
  Cascione L, Rinaldi A, Bruscaggin A, Tarantelli C, Arribas AJ, Kwee I, Pecciarini L, Mensah AA, Spina V, Chung EYL, di Bergamo LT, Dirnhofer S, Tzankov A, Miranda RN, Young KH, Traverse-Glehen A, Gaidano G, Swerdlow SH, Gascoyne R, Rabadan R, Ponzoni M, Bhagat G, Rossi D, Zucca E, Bertoni F
  Haematologica · PubMed

• Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19
  Plesa A, Labussiere-Wallet H, Hayette S, Salles G, Thomas X, Sujobert P
  Haematologica · PubMed

• Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
  Evrard SM, Pericart S, Grand D, Amara N, Escudie F, Gilhodes J, Bories P, Traverse-Glehen A, Dubois R, Brousset P, Parrens M, Laurent C
  Haematologica · PubMed

• Molecular analysis of a CD19-negative diffuse large B-cell lymphoma
  Delage L, Manzoni D, Quinquenet C, Fontaine J, Maarek A, Chabane K, Mosnier I, Hayette S, Callet-Bauchu E, Grange B, Plesa A, Sujobert P
  Haematologica · PubMed

• Finely-tuned regulation of AMP-activated protein kinase is crucial for human adult erythropoiesis
  Ladli M, Richard C, Aguilar LC, Ducamp S, Bondu S, Sujobert P, Tamburini J, Lacombe C, Azar N, Foretz M, Zermati Y, Mayeux P, Viollet B, Verdier F
  Haematologica · PubMed

• The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
  Sujobert P, Le Bris Y, de Leval L, Gros A, Merlio JP, Pastoret C, Huet S, Sarkozy C, Davi F, Callanan M, Thieblemont C, Sibon D, Asnafi V, Preudhomme C, Gaulard P, Jardin F, Salles G, Macintyre E
  Hemasphere · PubMed

• Don’t Kill the WASP!
  Tesio M
  Hemasphere · PubMed

• High-Resolution Pictures of AML Hierarchies
  Tesio M
  Hemasphere · PubMed

• Filling the GAP (DH) in Pre-Clinical Models
  Tesio M
  Hemasphere · PubMed

• Aggressive large B-cell lymphoma triggered by a parvovirus B19 infection in a previously healthy child
  Olivier-Gougenheim L, Dijoud F, Traverse-Glehen A, Benezech S, Bertrand Y, Latour S, Frobert E, Donnenech C
  Hematological Oncology · PubMed

• Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes
  Unzu C, Planet E, Brandenberg N, Fusil F, Cassano M, Perez-Vargas J, Friedli M, Cosset FL, Lutolf MP, Wildhaber BE, Trono D
  Hepatology · PubMed

• Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study
  Benech N, Dumitrescu O, Conrad A, Balsat M, Paubelle E, Ducastelle-Lepretre S, Labussiere-Wallet H, Salles G, Cohen S, Goutelle S, Ader F, Ader F, Alcazer V, Bachy E, Balsat M, Barraco F, Boccard M, Billaud G, Chidiac C, Conrad A, Ducastelle-Lepretre S, Dumitrescu O, Dupont D, Escuret V, Ferry T, Frobert E, Ghesquieres H, Heiblig M, Labussiere-Wallet H, Larcher MV, Laurent F, Lina B, Lina G, Menotti J, Miailhes P, Monneret G, Morfin-Sherpa F, Paubelle E, Perpoint T, Rabodonirina M, Renault M, Roure-Sobas C, Salles G, Thomas X, Valour F, Venet F, Wallet F, Wallon M
  Journal of Antimicrobial Chemotherapy · PubMed

• Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
  Bachy E, Seymour JF, Feugier P, Offner F, Lopez-Guillermo A, Belada D, Xerri L, Catalano JV, Brice P, Lemonnier F, Martin A, Casasnovas O, Pedersen LM, Dorvaux V, Simpson D, Leppa S, Gabarre J, da Silva MG, Glaisner S, Ysebaert L, Vekhoff A, Intragumtornchai T, Le Gouill S, Lister A, Estell JA, Milone G, Sonet A, Farhi J, Zeuner H, Tilly H, Salles G
  Journal of Clinical Oncology · PubMed

• Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
  Sarkozy C, Maurer MJ, Link BK, Ghesquieres H, Nicolas E, Thompson CA, Traverse-Glehen A, Feldman AL, Allmer C, Slager SL, Ansell SM, Habermann TM, Bachy E, Cerhan JR, Salles G
  Journal of Clinical Oncology · PubMed

• Prevalence of human herpesviruses infections in nonmalignant tonsils: The SPLIT study
  Kourieh A, Gheit T, Tommasino M, Dalstein V, Clifford GM, St Guily JL, Clavel C, Franceschi S, Combes JD, Albert S, Barry B, Hourseau M, Picard A, Berrebi D, Van Den Abbeele T, Teissier N, Denoyelle F, Galmiche-Rolland L, Leboulanger N, Couloigner V, de Crouy-Chanel O, Lefevre M, Lesnik M, Perie S, Samaha S, Coulomb A, Denoux Y, Badet JM, Mauvais O, Mougin C, Pretet JL, Valmary-Degano S, Babin E, Lechapt-Zalchman E, Brambilla E, Lantuejoul S, Righini C, Bessede JP, Coulibaly B, Lerat J, Berger F, Traverse-Glehen A, Ceruse P, Cosmidis A, Costes V, Garrel R, Cassagnau E, Malard O, Chapuis H, Lallemant B, Dufour X, Frouin E, Levillain P, Birembaut P, Caudroy S, Diebold MD, Merol JC, Uro-Coste E, Vergez S, Moriniere S, Rousselot C, Onea M, Schultz P, Bach C, McKay-Chopin S
  Journal of Medical Virology · PubMed

• Unravelling Subtleties of Angioimmunoblastic T-Cell Lymphoma
  Bachy E, Salles G
  Journal of Oncology Practice · PubMed

• Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations
  Xochelli A, Bikos V, Polychronidou E, Galigalidou C, Agathangelidis A, Charlotte F, Moschonas P, Davis Z, Colombo M, Roumelioti M, Sutton LA, Groenen P, van den Brand M, Boudjoghra M, Algara P, Traverse-Glehen A, Ferrer A, Stalika E, Karypidou M, Kanellis G, Kalpadakis C, Mollejo M, Pangalis G, Vlamos P, Amini RM, Pospisilova S, Gonzalez D, Ponzoni M, Anagnostopoulos A, Giudicelli V, Lefranc MP, Espinet B, Panagiotidis P, Piris MA, Du MQ, Rosenquist R, Papadaki T, Belessi C, Ferrarini M, Oscier D, Tzovaras D, Ghia P, Davi F, Hadzidimitriou A, Stamatopoulos K
  Journal of Pathology · PubMed

• PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma reply
  Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Berriolo-Riedinger A, Fornecker LM, Andre M, Meignan M
  Lancet Oncology · PubMed

• PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
  Casasnovas RO, Bouabdallah R, Brice P, Lazarovici J, Ghesquieres H, Stamatoullas A, Dupuis J, Gac AC, Gastinne T, Joly B, Bouabdallah K, Nicolas-Virelizier E, Feugier P, Morschhauser F, Delarue R, Farhat H, Quittet P, Berriolo-Riedinger A, Ternpescul A, Edeline V, Maisonneuve N, Fomecker LM, Lamy T, Delmer A, Dartigues P, Martin L, Andre M, Moonier N, Traverse-Glehen A, Meignan M
  Lancet Oncology · PubMed

• Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
  Pfeifer H, Cazzaniga G, van der Velden VHJ, Cayuele JM, Schafer B, Spinelli O, Akiki S, Avigad S, Bendit I, Borg K, Cave H, Elia L, Reshmi SC, Gerrard G, Hayette S, Hermanson M, Juh A, Jurcek T, Chillon MC, Homburg C, Martinelli G, Kairisto V, Langen T, Lion T, Mueller MC, Pane F, Rai L, Damm-Welk C, Sacha T, Schnittger S, Touloumenidou T, Valerhaugen H, Vandenberghe P, Zuna J, Server H, Herrmann E, Markovic S, van Dongen JJM, Ottmann OG
  Leukemia · PubMed

• Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experience
  Heiblig M, Sujobert P, Hayette S, Balsat M, Elhamri M, Salles G, Thomas X
  Leukemia Research · PubMed

• Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
  Perez-Vargas J, Amirache F, Boson B, Mialon C, Freitas N, Sureau C, Fusil F, Cosset FL
  Nature Communications · PubMed

• Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
  Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massourides E, Sohier TJM, Corbin A, Aube F, Teixeira M, Pinset C, Schaeffer L, Legube G, Cosset FL, Verhoeyen E, Ohlmann T, Ricci EP
  Nature Communications · PubMed

• Tracing the ancestry of modern bread wheats
  Pont C, Leroy T, Seidel M, Tondelli A, Duchemin W, Armisen D, Lang D, Bustos-Korts D, Goue N, Balfourier F, Molnar-Lang M, Lage J, Kilian B, Ozkan H, Waite D, Dyer S, Letellier T, Alaux M, Russell J, Keller B, van Eeuwijk F, Spannagl M, Mayer KFX, Waugh R, Stein N, Cattivelli L, Haberer G, Charmet G, Salse J
  Nature Genetics · PubMed

• A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study
  Labreche K, Daniau M, Sud A, Law PJ, Royer-Perron L, Holroyd A, Broderick P, Went M, Benazra M, Ahle G, Soubeyran P, Taillandier L, Chinot OL, Casasnovas O, Bay JO, Jardin F, Oberic L, Fabbro M, Damaj G, Brion A, Mokhtari K, Philippe C, Sanson M, Houillier C, Soussain C, Hoang-Xuan K, Houlston RS, Alentorn A, Moles-Moreau MP, Gressin R, Delwail V, Morschhauser F, Agape P, Jaccard A, Ghesquieres H, Tempescul A, Gyan E, Marolleau JP, Houot R, Fornecker L, Di Stefano AL, Detrait I, Rahimian A, Lathrop M, Genet D, Davi F, Cassoux N, Touitou V, Choquet S, Vital A, Polivka M, Figarella-Branger D, Benouaich-Amiel A, Campello C, Charlotte F, Martin-Duverneuil N, Feuvret L, Kas A, Navarro S, Villa C, Bielle F, Chretien F, Tortel MC, Gauchotte G, Uro-Coste E, Godfrain C, Rigau V, Costopoulos M, Le Garff-Tavernier M, Meyronnet D, Rousseau A, Adam C, Lamy T, Chabrot C, Boyle EM, Blonski M, Schmitt A
  Neuro-Oncology · PubMed

• Locus suicide recombination actively occurs on the functionally rearranged IgH allele in B-cells from inflamed human lymphoid tissues
  Dalloul I, Boyer F, Dalloul Z, Pignarre A, Caron G, Fest T, Chatonnet F, Delaloy C, Durandy A, Jeannet R, Lereclus E, Boutouil H, Aldigier JC, Peron S, Le Noir S, Cook-Moreau J, Cogne M
  Plos Genetics · PubMed

• Follicular lymphoma: An update
  Sujobert P, Salles G
  Presse Medicale · PubMed

• Cooption of the pteridine biosynthesis pathway underlies the diversification of embryonic colors in water striders
  Vargas-Lowman A, Armisen D, Floriano CFB, Cordeiro IDS, Viala S, Bouchet M, Bernard M, Le Bouquin A, Santos ME, Berlioz-Barbier A, Salvador A, Moreira FFF, Bonneton F, Khila A
  Proceedings of the National Academy of Sciences of the United States of America · PubMed